cleaned_up_drug	class_umls
BR55	
SGT-53	
PVSRIPO	
anti-PSMA	
BKM120	
BKM120	
darolutamide	
APG-2575	
anti-Mesothelin	
INC280	
INC280	
INC280	
INC280	
INC280	
INC280erlotinib	
Platinum/pemetrexed	
M7824HER2+	
Chemotherapy	
anti-MESOCAR-T	
Fluorine-181-amino-3-fluorocyclobutane-1-carboxylicFACBC	
18F-DCFPyL	
18F-Fluciclovine	
CNCT19	
FPA150	
Vitamin	
BTG-002814vandetanib-elutingradiopaque	
ET019002-	
ET019002-	
ET019002-	
18F-fluciclovine	
radium-223	
radium-223	
radium-223	
radium-223	
lapatinibditosylate	
paclitaxelalbumin-stabilizednanoparticle	
Talimogenelaherparepvec	
DurvalumabMedi4736	
pd-1dc-cik	
pd-1DC-NK	
F-18	
irinotecantemozolomidebevacizumabalkylator	
DenosumabMG/1.7SubcutaneousXGEVA	
ElutingTransarterialChemoembolization	
SorafenibET140202-T	
ET140202-T	
ET140202-T	
AB-101	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
LCAR-C182A/LCAR-C182B/LCAR-C182C	
anti-MESOCAR-T	
CLL1-CD33cCAR	
CB-03-10	
EribulinMesylate	
Vitamin	
SR-T100Solanumundatum	
sorafenibtosylate	
P15-041	
Sitravatinib	
Sitravatinib	
GVAX	
IMC-CS4	
PorfimerSodium	
IFx-Hu2.0	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
CD137	
F-18VM4-037	
Anti-Smoking	
AutologousEBV-CTLSFG-CNA12	
AutologousEBV-CTLSFG-CNA8	
Anti-BCMACAR-T	
BCMACAR-T	
Anti-BCMA	
LenalidomideDexamethasoneMEDI-551	
PU-AD	
RGD-K5	
Intra-lesionalnivolumab	
ODSH	
Fimepinostat	
extracorporealphotopheresis	
recMAGE-A3AS15ASCI	
CD19-TriCAR-T/SILK	
CD19-TriCAR-T/SILK	
MB-CART20.1	
GPA-TriMAR-T	
bortezomibG-CSF	
Spartalizumab	
Spartalizumab	
Spartalizumab	
Canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
Canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
Canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
GadoliniumDTPA	
SacituzumabGovitecan	
Tasigna	Protein kinase inhibitors|Bcr-Abl Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
GAA/TT-peptidevaccinepoly-ICLC	
CD19-CD22CAR-T	
Anti-CD19/CD22	
Anti-CD19iCAR	
Anti-CD22	
Anti-CD19	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Burosumab	Other drugs affecting bone structure and mineralization|IMMUNOLOGICAL AGENTS,OTHER
SNX-5422	
SNX-5422	
SNX-5422	
MEDI-551	
MEDI-551	
MEDI-551	
Paclitaxel+Reparixin	
Urelumab	
enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
MSB0011359C	
Evofosfamide	
AGS-1C4D4	
AB928	
AB928	
AB928	
AB928	
IPI-549	
IPI-549	
IPI-549	
liposomaldoxorubicin	
albumin-boundpaclitaxel	
CTX-471	
SNX-5422	
SNX-5422	
SNX-5422	
ASG-5ME	
ASG-5ME	
MEDI-575	
INCB028060	
WT2725	
TriciribineMonohydrate	
TBI-1401HF10	
BelinostatWarfarin	
SAR441000	
CemiplimabREGN2810	
DoxorubicinHydrochlorideLiposome	
eRaparapamycin	
grapiprant	
grapiprantpembrolizumab	
PalloV-CC	
MDV3100	
MDV3100	
MDV3100	
MDV3100	
AR-67DB-67	
MDV3100	
MDV3100	
MDV3100	
MDV3100	
CVA21/pembrolizumab	
OMP-21M18	
OMP-21M18	
M4344	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
TB-403	
TB-403	
TB-403	
TB-403	
Hu5F9-G4	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Demcizumab	
Abraxane®	
Volitinib	
Cemiplimab	ANTINEOPLASTIC,OTHER
Cemiplimab	ANTINEOPLASTIC,OTHER
GM-CSF	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
GB226	
Fruquintinib	
Fruquintinib	
Fruquintinib	
Ridaforolimus	
Ridaforolimus	
ODM-201	
ODM-201	
ODM-201	
ODM-201	
ODM-201	
ODM-201	
ODM-201	
ODM-201	
ODM-201	
REGN3767	
cemiplimab	ANTINEOPLASTIC,OTHER
cemiplimab	ANTINEOPLASTIC,OTHER
MEDI4736Durvalumab	
rSIFN-co	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
AVE0005	
AVE0005	
Binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Cabiralizumab	
nanoparticulatepaclitaxel	
SAR405838	
SAR405838	
SAR405838	
SAR405838	
Pimasertib	
Galunisertib	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
HMPL-523	
AfliberceptAVE0005	
AfliberceptAVE0005	
DocetaxelXRP6976	
Prexasertib	
BAY94-9343	
BAY94-9343	
BAY94-9343mg/kg	
BAY94-9343mg/kg	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
enfortumabvedotin	
Demcizumab	
TalimogeneLaherparepvec	
TLD1433photodynamictherapy	
MCLA-158	
SHR3680SHR3162	
REGN421SAR153192	
E7386	
E7386	
E7386	
E7386	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
CYAD-101	
LY2624587	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
EOC202	
Brivanib	
Brivanib	
Brivanab	
JX-594	
JX-594	
SNX-5422	
SNX-5422	
SNX-5422	
OMP-54F28Nab-PaclitaxelGemcitabine	
Vantictumab	
MVT-5873	
CC-95251	
MSC1936369B	
MSC1936369B	
MSC1936369B	
MSC1936369B	
SRF231	
cis-UCA	
TAS-114/capecitabine	
CPX-351Cytarabine	
INCMGA00012	
NK0125-FU	
LY2780301	
Alecsat	
LY2523355	
LY2523355	
olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
BLZ-100	
Xentuzumab	
Xentuzumab	
Xentuzumab	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
OMP-54F28Sorafenib	
sphingosinekinase-2inhibitorABC294640	
MGAH22	
Comparator	
Comparator	
Comparator	
Comparator	
Comparator	
BLZ-100	
MM-121	
EC20	
EC20	
LY900009Escalation	
LY900009	
ODM-201	
ODM-201	
ODM-201	
PF-03084014	
PF-03084014	
tivantinib	
s-warfarin	
NEO-PV-01	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
AnetumabravtansineBAY94-9343	
LiposomalDoxorubicin	
Vantictumabpaclitaxel	
Ad/PNPfludarabinemonophosphate	
LY2523355	
LY2523355	
CS-7017	
CS-7017	
CS-7017	
LY3076226	
imexon	
ES414	
ARN-509	
ARN-509	
ARN-509	
sunitinibFOLFOX	
AbGn-7	
ADI-PEG	
AdV-tkaglatimagenebesadenovecvalacyclovir	
AZD6244	
AZD6244	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
FS118	
Nerofe	
Nerofe	
Nerofe	
CM082	
TVB-2640	
TAS3681	
IMMU-130	
TelatinibMesylate	
BrivanibCetuximab	
LTX-315	
LTX-315	
LTX-315	
LTX-315	
LTX-315	
LTX-315	
LTX-315ipilimumab	
LTX-315pembrolizumab	
IPI-926	
IPI-926	
IPI-926	
FPA144mFOLFOX6	
PF-05082566	
mg/m2	
mg/m2	
mg/m2	
mg/m2	
mg/m2	
mg/m2	
AB-16B5	
AB-16B5	
AZD8330	
AZD8330	
AZD8330	
SHR-1701	
OCV-103OCV-104	
ADH300004	
SHR-1701	
PWT33597mesylate	
RidaforolimusDalotuzumab	
Ridaforolimus	
Ridaforolimus	
Dalotuzumab	
TKI258	
TKI258	
CC-90002	
Angiocal®PRS-050-PEG40	
Pyrotinib	
SNX-5422	
SNX-5422	
SNX-5422	
TRC105chimericanti-CD105antibody	
MLN0128	
MLN0128	
MLN0128	
BLZ-100	
MEDI3726Post-Chemo	
MEDI3726Pre-Chemo	
MEDI3726EnzalutamideCombo	
CPGJ602	
MKC-1	
MKC-1	
MKC-1	
ETBX-021	
TRC093IgG1kantibody	
SNX-5422	
SNX-5422	
SNX-5422	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
PF-04554878	
PF-04554878	
BBI608	
Levofolinate	
antibody	
chemotherapy	
MEN1611	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
CRA-24781	
AmphinexTPCS2a	
enzastaurinhydrochloride	
Afuresertib	
ALT-P7HM2-MMAE	
BKM120	
BKM120	
AZD5438	
AZD5438	
AZD5438	
NK012carboplatin	
BP-C1	
TivozanibAV-951FOLFOX6	
EC1456	
EC1456	
EC1456	
EC1456	
99mTc-Etarfolatide	
IMGN853	
FS-1502	
Prexasertib	
G-CSF	BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
LY3023414	
LY3023414	
LY3023414	
OshadiOshadi	
MM-121	
APR-246	
APR-246	
APR-246	
APR-246	
KN026	
ABI-011	
Denenicokin	
RX108	
Perifosine	
Perifosine	
Apatinibrivoceranib	
CEP-37440	
CEP-37440	
CEP-37440	
BMS-754807	
BMS-754807	
BMS-754807	
BMS-754807	
AVB-620	
DN-101	
MVA-BN-PRO	
Nanoparticlealbumin-boundpaclitaxel	
E7974	
PSA-ActivatedPSA-PAH1	
Lapatinibanti-cancer	
Lapatinibanti-cancer	
KU-0059436AZD2281PARPinhibitor	
SGN-LIV1A	
INCMGA00012	
Epacadostat	
INCB050465	
E7974	
JNJ-212082	
Pemigatinib	
Pemigatinib	
LJM716	
TT-00420	
OMP-313M32	
BAY1251152	
MobilanM-VM3	
TrastuzumabderuxtecanDS-8201a	
triapine	
triapine	
FG-3019	
FG-3019	
MVA-BN-HER2	
JNJ-56021927	
JNJ-56021927	
IMAB027	
E7386	
E7386	
E7386	
E7386	
AZD3514	
AZD3514	
AZD3514	
AUY922	
AUY922	
AUY922	
AUY922	
AUY922	
BYL719	
BYL719	
BYL719	
BYL719	
ALECSAT	
GDC-0077	
GDC-0077	
GDC-0077	
GDC-0077	
ARV-110	
BP31510monotherapy	
BP31510chemotherapy	
PX-12	
PX-12	
CTT1403	
CTT105768Ga-PSMA-11	
liposomalhydrochloride	
GM102	
Paclitaxelcarboplatin	
XMT-1107	
FarletuzumabCarboplatin	
MLN0128	
MLN0128	
MLN0128	
LY2495655	
LY2495655	
LY2495655	
LY2495655	
PSB205	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
ABBV-011	
ABBV-181	
ABBV-181	
ARX788	
Poziotinib	
Poziotinib	
MEDI3617	
JTX-4014	
KN026	
PF-05212384gedatolisib	
Dacomitinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER
Dacomitinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER
JNJ-64041809	
JNJ-64041809	
M8891	
ALECSAT	
GDC-9545	
Ipatasertib	
hMAbBIWA	
hMAbBIWA	
unlabelledhMAbBIWA	
unlabelledhMAbBIWA	
unlabelledhMAbBIWA	
INCB024360	
MVA-BN-HER2	
KHK2375	
TK006	
SAR439859	
EC90KLH-FITC	
GPI-0100	
GPI-0100	
GPI-0100	
EC17Folate-FITC	
Interferon-alpha	
EPC2407crinobulin	
Tykerb	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|HER2/Neu/cerbB2 Antagonists|Protein Kinase Inhibitors|Kinase Inhibitor
Hemay022	
CP-751,871	
ALN-VSP02	
MK-8353	
GEM3PSCA	
Anthracyclinedoxorubicin	
M3541	
DHES0815A	
D-0502	
HuC242-DM4	
MM-111Herceptin	
AK112	
MEDI-573	
P1446A-05	
PazopanibGW786034	
BCD-115	
JNJ-56021927	
JNJ-56021927	
ABT-414	
ABT-414	
omaveloxolone	
omaveloxolone	
Avapritinib	
CUDC-101	
CUDC-101	
CUDC-101	
BAY94-9392	
Ipatasertib	
AromataseInhibitor	
Glucocorticoid	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
ImmunotherapeuticSB719125	
AZD9833	
AZD9833palbociclib	
ImetelstatSodiumGRN163L	
BVAC-B	
Resiniferatoxin	
Resiniferatoxin	
PDR001	
PDR001	
PDR001	
PDR001	
OPB-51602	
NOX66	
AS703569/gemcitabine	
AB928	
AB928	
AB928	
AB928	
mFOLFOX	
TrastuzumabEmtansine	
LY2940680	
LY2940680	
GDC-9545	
GDC-0927	
GDC-0927	
GDC-0927	
TTI-621	
TTI-621Rituximab	
TTI-621Nivolumab	
BYL719	
BYL719	
BYL719	
BYL719	
GSK525762	
GSK525762	
GSK525762	
Abiraterone	Other hormone antagonists and related agents|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 17A1 Inhibitors|ANTINEOPLASTIC HORMONES|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 17A1 Inhibitor
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
OMP-54F28PaclitaxelCarboplatin	
LY2835219	
LY2835219	
LY3023414	
LY3023414	
LY3023414	
therapy	
HQP1351	
HQP1351	
OBP-301	
VM206DNA	
VM206Ad	
Perifosine	
Perifosine	
ASP1951	
LY3007113	
BYL719	
BYL719	
BYL719	
BYL719	
BKM120	
BKM120	
I-8H9	
KX2-361	
KX2-361	
KX2-361	
BAY2010112	
ABBV-621	
U3-1402	
INCMGA00012	
INCMGA00012INCB001158	
LY3295668Erbumine	
therapy	
LY3164530	
LY3164530	
LY3164530	
LY3164530	
ALIMTA	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
folic	
huMNC2-CAR44	
huMNC2-CAR44RP2D	
BEZ235Trastuzumabl/Phase	
LapatinibCapecitabine	
CNTO	
E7046	
folinicacid/5-FU/oxaliplatinmFOLFOX-6	
omeprazolebortezomib	
BOS172722	
bivatuzumabmertansine	
MAG-TN3AS15	
ADI-PEG	
TTAC-0001pembrolizumab	
123-I-MIP-1072	
111-Incapromabpendetide	
CombretastatinDiphosphateOXi4503	
Dextromethorphanhydrobromide	
AnetumabravtansineBAY94-9343	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
LY2090314	
LY2090314	
LY2090314	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
ZD6474Zactima	
ZD6474Zactima	
LY2157299	
LY2157299	
LY2157299	
RMC-4630	
DS-1123	
EPO906patupilone	
mRNA-4157	
encorafenib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|BRAF Serine/Threonine Kinase Inhibitors
binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
RegorafenibStivargaBAY73-4506	
Cixutumumab	
LSZ102	
LSZ102	
LSZ102	
LSZ102	
BYL719	
BYL719	
BYL719	
BYL719	
Rovalpituzumabtesirine	
AZD8835	
AZD8835	
AZD8835	
AZD8835	
AZD8835fulvestrant	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Danvatirsen	
Oleclumab	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
dalotuzumabMK0646	
trastuzumabemtansine	
MGD013	
MGD013margetuximab	
BYL719	
BYL719	
BYL719	
BYL719	
anticancerIC01	
LY3022855	
LY3022855	
PTC299	
PTC299	
GSK2110183	
GSK2110183	
AZD3514	
AZD3514	
AZD3514	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
AZD8931	
AZD8931	
SGN-LIV1A	
MLN0128	
MLN0128	
MLN0128	
ASP1948	
EribulinMesylate	
Lumretuzumab	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
SPI-2012	
GSK1795091	
GSK3174998	
GSK3174998	
GSK3174998	
GSK3174998	
GSK3359609	
BGJ398	
BGJ398	
BGJ398	
BGJ398	
BYL719	
BYL719	
BYL719	
BYL719	
pyrotinibcapecitabine	
DOXIL/CAELYX	
DOXIL/CAELYX	
erlotinibhydrochloride	
gemcitabinehydrochloride	
Sulfatinib	
MGCD516	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
TQB2450AnlotinibHydrochioride	
RAD1901	
GemcitabineNab-paclitaxel	
E7820	
E7820	
E7820	
PRO95780	
PRO95780	
PRO95780	
AG-221	
AG-221	
rhPSMA-7.3	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
Tucatinib	
Tucatinib	
anti-HER2antibodyinjection.R	
CVA21	
Mitomycin	ANTINEOPLASTIC ANTIBIOTICS|ANTIGLAUCOMA,OTHER|Other cytotoxic antibiotics|Alkylating Activity|Nucleic Acid Synthesis Inhibitors|Alkylating Drug
TAS-102	
TAS-102	
TAS-102	
CBL0137	
CBL0137	
CBL0137	
RAD140	
RAD140	
RAD140	
RAD140	
RAD140	
RAD140	
RG1507	
RG1507	
GDC-0980	
GDC-0980	
GDC-0980	
everolimusRAD001	
panitumumabABX-EGF	
spartalizumab	
spartalizumab	
spartalizumab	
LAG525	
LAG525	
NIR178	
capmatinib	
MCS110	
canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
AZD1775	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
AZD1775	
TrifluridineTipiracil	
TAS-102	
TAS-102	
TAS-102	
KPG-121escalationEnzalutamide	
Taselisib	
Trastuzumabemtansine	
SorafenibNexavarBAY43-9006	
TTC-352	
Fluzoparib	
OMP-54F28	
OMP-54F28	
OMP-54F28	
Buparlisib	
KU-0059436AZD2281PARPinhibitor	
POL6326	
gemcitabinecisplatin	
E7389gemcitabinecisplatin	
AZD3759	
AZD3759	
AZD3759	
AZD3759	
ABBV-155	
ALT-803	
ALT-803	
HumanizedBispecificAntibodyMBS301	
LBH589panobinostat	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
GSK3174998	
GSK3174998	
GSK3174998	
GSK3174998	
Platinum-based	
LY01005	
CriPec®docetaxel	
Fluzoparib	
Apatinib	
Apatinib	
Apatinib	
OTS167IV	
ZEN003694	
GDC-0941	
GDC-0941	
L-DOS47	
ASP9801	
OMP-336B11	
MTIG7192A	
BEZ235MEK162	
INO-5150electroporationCELLECTRA®-5P	
INO-5150electroporationCELLECTRA®-5P	
INO-5150INO-9012electroporationCELLECTRA®-5P	
INO-5150INO-9012electroporationCELLECTRA®-5P	
AMN107STI571	
Antroquinonol	
Antroquinonol	
Antroquinonol	
GSK2141795	
GSK2141795	
EP2101	
EP2101	
ElesclomolSodium	
FOR46	
RGX-104	
Pictilisib	
FOLFOX	
FOLFOX	
dulanermin	
pLADD	
AZD5363	
AZD5363	
AZD5363	
FOLFOX	
FOLFOX	
PRO95780	
PRO95780	
PRO95780	
Gimatecan®ST-1481	
XMT-1536	
Apatinibmesylate	
SPARC1613	
Reference1613	
SunitinibSutent	
SHR9549	
Ficlatuzumab	
PF-06755992	
PF-06755990	
PF-06801591	
OB318	
AGS67E	
NEV801	
ALT-836gemcitabine	
EC20	
EC20	
HPN424	
RUTI®	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
SYN004	
VXM01	
INO-3106INO-9012	
MUC1-gene-DC-CTL	
MUC1-peptide-DC-CTL	
Hemay022	
GX-188Eelectroporation	
NIZ985	
PDR001	
PDR001	
PDR001	
PDR001	
CirmtuzumabPaclitaxel	
Custirsenpaclitaxelcarboplatin	
ANG1005	
ANG1005	
MEHD7945A	
MEHD7945A	
MEHD7945A	
MEHD7945A	
BKM120MEK162	
LiposomePaclitaxel	
ridaforolimus	
ridaforolimus	
MK-0752	
MK-0752	
MK-0752	
MK-0752	
MK-0752	
MK-0752	
MK-2206	
MK-2206	
MK-2206	
MK-2206	
MK-2206	
VXM01	
LErafAON	
sunitinibmFOLFOX6	
BN83495	
BN83495	
BN83495	
BN83495	
BN83495	
BN83495	
MCLA-145	
JNJ-26481585	
ABBV-399	
PSMA	
P16-093	
STA-9090ganetespibDocetaxel	
LErafAON-ETU	
DMUC4064A	
Docetaxelmg/m^2	
Glufosfamide	
Glufosfamide	
LY3434172	
KO-947	
KO-947	
KO-947	
SCT200	
AGEN1181	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
LiposomePaclitaxelLEP-ETU	
PaclitaxelTaxol	
PD-L1t-haNK	
DM-CHOC-PEN	
AGS-22M6E	
ASG-22CE	
PG545	
PG545	
PG545	
PG545	
Monotherapy	
pegolPembrolizumabTherapy	
BPX-201vaccineAP1903	
LY2157299	
LY2157299	
LY2157299	
SHR-1501	
PSMA	
EverolimusBIBF	
ABBV-151	
ABBV-181	
ABBV-181	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AMC303	
MASCT-I	
antibody	
Chemophase	
Biologicals	
SunitinibPemetrexed	
CM082paclitaxel	
OsimertinibAZD9291	
SorafenibNexavarBAY43-9006	
MP-470	
MP-470	
amuvatinibMP-470	
IBI318	
AZD4547	
AZD4547	
AZD4547	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
AZD1775	
Vistusertib	
AZD9150	
AZD9150	
AZD9150	
Selumetinib	
tivozanibAV-951paclitaxel	
IMF-001	
Clostridiumnovyi-NT	
ABBV-368	
ABBV-181	
ABBV-181	
FOLFOX-4	
TAB08	
TAB08	
TAB08	
PF-06939999	
DSTP3086S	
Pyruvate	
Pyruvate	
CA102N	
LONSURF	Unknown Cellular or Molecular Interaction|ANTINEOPLASTIC,OTHER|Thymidylate Synthetase Inhibitors|Nucleoside Metabolic Inhibitor|Antivirals|Nucleoside Analog Antiviral|Thymidine Phosphorylase Inhibitor|Nucleic Acid Synthesis Inhibitors|Thymidine Phosphorylase Inhibitors
MM-121	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
CabazitaxelXRP6258	
OTS167PO	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
ModraDoc006/r	
SHR-1501	
SHR-1316	
bengaldisodium	
SAR408701	
SAR408701	
SAR408701	
SAR408701	
SAR428926	
CA-4948	
TJ004309	
HM95573cobimetinib	
autologous	
Cetrelimab	
Cetrelimab	
PCA062	
PDR001	
PDR001	
PDR001	
PDR001	
tivozanibAV-951capecitabineXeloda®	
OMP-52M51	
OMP-52M51	
OMP-52M51	
brontictuzumab	
brontictuzumab	
trifluridine/tipiracil	Unknown Cellular or Molecular Interaction|ANTINEOPLASTIC,OTHER|Thymidylate Synthetase Inhibitors|Nucleoside Metabolic Inhibitor|Antivirals|Nucleoside Analog Antiviral|Thymidine Phosphorylase Inhibitor|Nucleic Acid Synthesis Inhibitors|Thymidine Phosphorylase Inhibitors
DCC-3014	
FPA144	
NBM-BMXsoftgel	
NBM-BMXsoftgel	
NPI-0052	
NPI-0052	
DPX-Survivac	
Relatlimab	
Prexasertib	
Prexasertib	
SHR2554	
Promitil	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Oleclumab	
Elacestrant	
Elacestrant	
Elacestrant	
ADI-PEG	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
KRN330	
MGCD265	
MGCD265	
MGCD265	
MGCD265	
MGCD265	
DM-CHOC-PEN	
U3-1402	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
BMS-641988	
P1446A-05	
ADXS31-142	
ADXS31-142PembrolizumabMK-3475	
REGN2810	
REGN2810	
REGN2810	
Platinum-doubletchemotherapy	
DS-6051b	
Anlotinib	
Anlotinib	
Anlotinib	
ES101	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
GSK3359609	
GSK3174998	
GSK3174998	
GSK3174998	
GSK3174998	
Docetaxelmg/m^2	
Pemetrexedmg/m^2Carboplatinmg/mL	
Paclitaxelmg/m^2Carboplatinmg/mL	
Gemcitabinemg/m^2Carboplatinmg/mL	
Fluorouracilmg/m^2carboplatincisplatin	
PVX-410	
HSP990	
HSP990	
HSP990	
EP-100	
EP-100	
EP-100	
TSR-022	
TSR-042anti-PD-1antibody	
TSR-033anti-LAG-3antibody	
Dalotuzumabmg/kg	
Dalotuzumabmg/kg	
XL184	
XL184	
XL184	
XL184	
XL184	
XL184	
KTN3379	
TAK-659	
TAK-659	
BPX-501	
rimiducid	
CopanlisibBAY80-6946	
MLN0264	
pbi-shRNASTMN1	
CetuximabIrinotecan	
Chlorogenic	
sunitinibmalate	
ALT-801	
ALT-801	
ALT-801	
ALT-801	
TSR-042	
ZD4054Zibotentan	
BBI608	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
SAR302503TG101348	
Panolosetron	
OSI-930	
OSI-930	
OSI-930	
OSI-930	
IBI188	
IBI188Rituximab	
L19TNFa	
MitoxantroneEnGeneIC	
LY2228820	
LY2228820	
IBI188	
LY2875358	
LY2875358	
LY2875358erlotinib	
LY2875358	
LY2875358	
LY2875358trametinib	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
sunitinibmalate	
AGS15E	
E7386	
E7386	
E7386	
E7386	
NanoplatinNC-6004Gemcitabine	
CP-675,206gemcitabine	
DS-1205c	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
PAN-301-1	
TRX-818	
AZD4635	
LY2835219	
LY2835219	
M3814	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
bevacizumabAvastin	
capecitabineXeloda	
erlotinibTarceva	
VX15/2503	
VX15/2503	
VX15/2503	
TalimogeneLaherparepvec	
binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
ABT-767	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
TopotecanLiposomes	
imexon	
SAR125844	
SAR125844	
SAR125844	
SAR125844	
cediranibRECENTINAZD2171	
EGEN-001phIL-12-005/PPC	
capecitabineXeloda	
Urelumab	
DFP-14927	
PCUR	
Sevacizumab	
OSI-930	
OSI-930	
OSI-930	
OSI-930	
MABp1	
CabazitaxelXRP6258	
methyl	
VCN-01	
Abraxane®	
MLN2704antibodyMLN591	
ZL-2306niraparib	
SAR245409	
SAR245409	
SAR245409	
REOLYSIN®	
MerckPembrolizumab	
GS-9820	
LY2835219	
LY2835219	
IniparibSAR240550-BSI-201	
Placlitaxel	
liposomaldoxorubicin	
U3-1565	
selumetinib	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Lirilumab	
IDH305	
IDH305	
PM02734	
PM02734	
dulanermin	
Tanibirumab	
4SC-202	
4SC-202	
4SC-202	
4SC-202	
4SC-202	
4SC-202	
CA-18C3	
7-t-butyldimethylsilyl-10-hydroxycamptothecin	
MEDI0680AMP-514	
afliberceptAVE0005	
P501-AS15vaccine	
MK-1697	
PAC-1	
PAC-1	
AZD9150Durvalumab	
SAR260301	
SAR260301	
SAR260301	
SAR260301	
GT0918	
GT0918	
GT0918	
MSC1936369Bpimasertib	
SAR245409PI3KmTORinhibitor	
CabazitaxelXRP6258	
AUY922	
AUY922	
AUY922	
AUY922	
AUY922	
ONC1-0013B	
PF-00299804	
AZD1775	
AZD1775	
NKR-2	
OPB-111077	
Intuvaxilixadencel	
CM082	
LY3022855	
LY3022855	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
SAR566658	
SAR566658	
MK2461	
MK2461	
MK2461	
MK2461	
MK2461	
MK2461	
DS-7423	
Comparator	
SLC-0111	
INCB040093	
INCB040093itacitinib	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
KHK2455	
CabazitaxelXRP6258	
Tirabrutinib	
Tirabrutinib	
Tirabrutinib	
Entospletinib	
CYP1A2caffeine	
CYP2C19omeprazole	
CYP3Amidazolam	
Kytrilgranisetron	
Wee-1kinaseinhibitorAZD1775	
Doxorubicinhydrochlorideliposome	
Tivantinib	
M200VolociximabCarboplatinPaclitaxelBevacizumab	
defactinib	
AVE8062	
AVE8062	
AVE8062	
OMP-305B83	
OMP-305B83	
OMP-305B83	
OMP-305B83	
OMP-305B83	
capecitabineXeloda	
AZD1208	
AZD1208	
AZD1208	
AZD1208	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
TrastuzumabemtansineKadcylamg/kg	
TrastuzumabemtansineKadcylamg/kg	
TRC105	
KPT-330	
KPT-330	
ANX-514	
Foxy-5	
Foxy-5	
Foxy-5	
Foxy-5	
RDEA119	
RDEA119	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
Promitil	
PF-04449913	
PF-04449913	
PF-04449913	
Ipatasertib	
SGN-LIV1A	
ChemotherapyGemcitabineCarboplatinEribulin	
RO6874281	
RO6874281	
RO6874281	
RO6874281	
Selicrelumab	
Selicrelumab	
NKR-2	
SB-485232interleukinliposomaldoxorubicin	
IntratumoralPolyICLC	
IntratumoralPolyICLC	
IntramuscularPolyICLC	
TAK-385	
TAK-385	
Foxy-5	
Foxy-5	
Foxy-5	
Foxy-5	
Demcizumab	
ErlotinibTarcevaOSI-774	
BevacizumabAvastinVEGF	
Brivanibalaninate	
BN80927	
BN80927	
BN80927	
MSC2156119J	
-SGMIBAnti-HER2VHH1	
PF-03446962	
MEDI4276	
MASCT-I	
pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
DMOT4039A	
tislelizumab	
tislelizumab	
pamiparib	
pamiparib	
JNJ-61186372	
MLN0128	
MLN0128	
MLN0128	
MLN0128	
MLN0128	
MLN0128	
MM-121	
XmAb18087	
XmAb18087	
BGB-3111Obinutuzumab	
ASP5878	
ASP5878	
ASP5878	
Lirilumab	
Trastuzumabemtansine	
NJH395	
Margetuximabpembrolizumab	
afliberceptAVE0005	
Chiauranib	
OMBRABULINAVE8062	
OmbrabulinAVE8062	
Sym013	
BBI608	
BBI503	
NKTR-214	
alisertib	
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
CNF2024	
CNF2024trastuzumab	
Eribulinmesylate	
IPH5401Durvalumab	
nesvacumabREGN910/SAR307746	
aflibercept	Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents
afliberceptAVE0005	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
OmbrabulinAVE8062	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
ombrabulinAVE8062	
Samarium-153	
AndrogenBicalutamide	
androgenGoserelin	
Itacitinib	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
BPX-101	
AP1903	
AP1903	
AP1903	
BEL-X-HG	
E7050	
E7050	
RegorafenibBAY73-4506	
VincristineCellcristin®	
IrinotecanIrinotecanpharm®	
capecitabineimatinibmesylate	
SAR125844	
SAR125844	
SAR125844	
SAR125844	
Oraxol	
CalciumAmor	
mg/m2CBDCAAUC5mg/mL*min	
BIBFmg/m2CBDCAAUC5mg/mL*min	
MLN2480	
MLN0128	
MLN0128	
MLN0128	
Alisertib	
ADU-S100	
ADU-S100	
ADU-S100	
M200VolociximabCarboplatinPaclitaxel	
Genexol-PMCarboplatin	
Genexol-PMCarboplatin	
Genexol-PMCarboplatin	
CS-1008antibody	
mRNA-2752	
mRNA-2752durvalumab	
mRNA-2752tremelimumab	
AMG820pembrolizumab	
FP-1039	
FP-1039	
FP-1039	
CapecitabineTarceva	
IMP4297	
etoposide/cisplatin	
NexavarSorafenibBAY43-9006	
IntravenousMK-3475/Intravesical	
GX-188E	
Trimix	
Trimix	
Trimix	
BIND-014	
BIND-014	
BIND-014	
LYC-55716	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
XMT-1001	
XMT-1001	
TQB2450	
Anlotinib	
Anlotinib	
Anlotinib	
RRx-001	
RRx-001	
RRx-001	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
LiposomalDoxorubicin	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Ferumoxytol	IRON|Parenteral Iron Replacement|Electrolyte Activity
Ferumoxytol	IRON|Parenteral Iron Replacement|Electrolyte Activity
MM-398	
SU014813	
SU014813	
ridaforolimus	
ridaforolimus	
RO7051790	
HM30181AKIrinotecan	
TPX-0022	
SHR9146+SHR-1210	
SHR9146+SHR-1210+Apatinib	
F0002-ADC	
DS-1205c	
IMC-TR1	
HM30181AKIrinotecan	
CMP-001	
imatinibmesylate	
CBP501Cisplatin	
rHuPH20	
rHuPH20	
SPARC-08-038	
Ref-08-038	
RAD001everolimus	
PTK787vatalanib	
HMPL-523	
Sulfatinib	
LY2334737	
LY2334737	
LY2334737	
LY2334737	
Tirabrutinib	
Tirabrutinib	
Tirabrutinib	
MDV3100	
MDV3100	
MDV3100	
MDV3100	
Pazopanibpaclitaxel	
rovalpituzumabtesirine	
Docetaxel-PNP	
ODM-201	
ODM-201	
ODM-201	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
CCI-779temsirolimus	
XL765SAR245409	
APG-1252	
ImetelstatSodiumGRN163L	
Comparator	
enoblituzumabipilimumab	
ImatinibPTK/ZK222584	
LDE225	
LDE225	
BIIB022PaclitaxelCarboplatin	
XL147SAR245408	
ACY-241	
TAK-228	
isomaltoside	
isomaltoside	
BGB-3111	
GM-CT-01	
OCPMImmunotherapeuticVaccine	
AS703569	
AS703569	
AS703569	
APG-1252	
MM-121SAR256212	
Anti-OX40	
CV301	
TKI258	
TKI258	
Talimogenelaherparepvec	
TAK-733	
TAK-733	
TAK-733	
TAK-733	
alpelisibBYL719	
buparlisibBKM120	
PTK787/ZK222584Bevacizumab	
iNeo-Vac-P01	
BMS-690514	
BMS-690514	
BMS-690514	
AGS-8M4	
AC0010MA	
AC0010MA	
LY3039478	
LY3039478	
LY3039478	
HS-10241	
EMB-01	
PF-06952229	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Enadenotucirev	
PRS-343	
PorfimerSodium	
AVX701	
SF1126	
SF1126	
SF1126	
SF1126	
SHR3162	
PGV001	
NBF-006	
famitinibdocetaxel	
famitinibdocetaxel	
famitinibdocetaxel	
Oprozomib	
MEDI6469	
MEDI6469	
TSR-042	
AZD7648	
liposomaldoxorubicin	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
BMK120	
BYL719	
BYL719	
BYL719	
BYL719	
ridaforolimus	
ridaforolimus	
Perifosine	
Perifosine	
SunitinibMalate	
AB0024	
AB0024	
AB0024	
Sym022	
Sym022	
Sym022	
Sym022	
Sym023	
Intra-lesionalGM-CSF	
GRASPA	
TAK700	
TAK700	
Tivantinib	
Tivantinib	
Tivantinib	
RO5323441	
ridaforolimus	
ridaforolimus	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
RAD001everolimusCisplatin	
PRS-343Atezolizumab	
Anti-MacrophageInhibitoryAnti-MIFAntibody	
FOLIRI	
FOLIRIE7820	
FOLFIRIBevacizumab	
lurbinectedinPM01183	
DMUC5754A	
DMUC5754A	
DMUC5754A	
DMUC5754A	
Ad-RTS-hIL-12	
veledimex	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
CC-115	
CC-115	
CC-115	
RAD001docetaxelcisplatin	
BYL719	
BYL719	
BYL719	
BYL719	
LJM716	
123-I-MIP-1072	
123-I-MIP-1095	
INCB086550	
OratecanCapecitabine	
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
13-cis-retinoic	
XL765SAR245409	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
gemcitabineirinotecanleucovorin5-fluorouraciloxaliplatin	
E7974	
Dovitinib	
PF00562271	
PF00562271	
DPX-0907tumor-specificHLA-A2-restrictedpeptidepolynucleotideliposomeMontanideISA51	
IHL-305irinotecanliposome	
EPO906epothilone	
Dinaciclib	
Dinaciclib	
SV-BR-1-GM	
DPX-Survivac	
DPX-Survivac	
EribulinKetoconazole	
GSK1120212everolimus	
FCN-437	
Linifanib	
GefitinibBKM120	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
AV-299	
GSK3745417	
CopanlisibAliqopaBAY80-6946	
forodesinehydrochloride	
E7090	
E7090	
E7090	
E7090	
AvelumabMSB0010718C	
AxitinibAG-013736	
paclitaxelcarboplatin	
XMT-1522	
Tergenpumatucel-L	
Indoximod	
BMS-599626	
BMS-599626	
BMS-599626	
BMS-599626	
SGT-53	
PF-00299804	
TG01	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
131I-MIP-1095	
131I-MIP-1095	
MEDI0562	
MEDI0562	
NPI-2358	
NPI-2358	
Porfimersodium	
Escalation	
Escalation	
Escalation	
Escalation	
Escalation	
Child-Pugh	
Child-Pugh	
NSCLC	
PledOxµmol/kg	
PledOxµmol/kg	
PledOxµmol/kg	
DNIB0600A	
ARGX-111	
Sym021	
Sym021	
Sym021	
Sym021	
Sym022	
Sym022	
Sym022	
Sym022	
Sym023	
DS-8895a	
MBP-426	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Photofrinporfimersodiumphotodynamictherapy	
ARRY-334543EGFR/ErbB2inhibitor	
IMC-CS4	
Brivanib	
Brivanib	
JNJ-26483327	
E7050	
E7050	
SNDX-6352	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
LCL161	
LCL161	
LCL161	
LCL161	
SGT-94	
E7050	
E7050	
RegorafenibBAY73-4506	
PF-00299804	
AK-104	
Eribulin-LF	
ID-LV305	
Trifluridine/tipiracilhydrochloride	
Ixabepilonemg/m^2Carboplatinmg/min/mL	
Ixabepilonemg/m^2Carboplatinmg/min/mL	
AB928	
AB928	
AB928	
AB928	
AB122	
AB122	
AB122	
AB122	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
DasatinibBMS-354825	
CetuximabErbituxC225	
MEDI0639	
MEDI0639	
MEDI0639	
IMC-3C5	
cetuximablapatinib	
Epacadostat	
LY573636	
LY573636	
LY573636	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
XL820	
CS1002	
RAD001BEZ235	
AZD1152	
AZD1152	
AZD1152	
AZD1152	
vorinostatSuberoylanilideHydroxamicSAHA	
ISU104	
IndiumIMP-205xm734	
Merestinib	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
MLN9708	
MLN9708	
MLN9708	
Nivolumab/Lirilumab	
Pexa-Vec	
E7130	
CMD-193	
CMD-193	
AVID200	
GDC-0994	
GDC-0994	
LY2584702	
LY2584702	
LY2584702	
LY2584702	
LY2584702	
LE-DT	
Pimasertib	
Pimasertib	
Pimasertib	
bsi-201topotecan	
bsi-201temozolomide	
bsi-201gemcitabine	
bsi-201carboplatin/paclitaxel	
SunitinibMalate	
MEGF0444A	
TAK-441	
TAK-441	
TAK-441	
AnlotinibPemetrexedCarboplatin	
ASONEPsonepcizumab/LT1009	
IT-pIL12-EP	
SodiumStibogluconate	
CVA21	
GO-203-2c	
GO-203-2c	
GO-203-2c	
MORAb-202	
AneustatOMN54	
AZD2461	
AZD2461	
AZD2461	
TalimogeneLaherparepvec	
decitabinegenistein	
OPB-111077	
SLC-391	
ZD4054Zibotentan	
INCB024360	
IMGN388	
FOLFOX	
FOLFOX	
MFGR1877S	
HLX10	
-Fluzoparib	
Volitinib	
PBF-999	
ADG106	
Chiauranib	
CapecitabineSorafenib	
CEND-1	
MEDI1873	
MEDI1873	
TAK-164	
ThermoDox	
Oprozomib	
CetuximabErlotinib	
cilengitideradiochemotherapy	
TAK-788	
Pegzilarginase	
Pegzilarginase	
Pegzilarginase	
Zoledronic	
apalutamide	GABA A Antagonists|Anti-androgens|ANTINEOPLASTIC,OTHER|Androgen Receptor Antagonists
CEP-9722	
CEP-9722	
CEP-9722	
CEP-9722	
CEP-9722	
capecitabineganetespib	
bevacizumabAvastin	
Prolantaprolactin	
HLX07	
5-HT3inhibitor	
bevacizumabAvastin	
EC1456EC20	
EGFRIL12	
PDR001	
PDR001	
PDR001	
PDR001	
NG-350A	
PLX3397	
PLX3397	
PLX3397	
V930	
V932	
Quisinostat	
topotecanhydrochloride	
GDC-0941	
GDC-0941	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
GDC-0425	
GDC-0425	
GDC-0425	
Pegilodecakin	
Pegilodecakin	
Pegilodecakin	
PaclitaxelDocetaxelCarboplatinCisplatin	
FOLFOXOxaliplatin/Leucovorin/5-Fluorouracil	
gemcitabine/nab-paclitaxel	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
Gemcitabine/carboplatin	
Gevokizumab	
FOLFOX6	
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
NG-641	
EC1169	
SNX-5422	
SNX-5422	
SNX-5422	
tucotuzumabcelmoleukin	
GSK2849330	
AdV-tk	
Selinexor	
Folinic	
OMP-131R10	
OMP-131R10	
AZD5153	
AZD5153	
AZD5153	
AZD5153	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
PanobinostatLBH589	
BYL719	
BYL719	
BYL719	
BYL719	
MEDI9447	
MEDI9447MEDI4736	
CC-223erlotinib	
CC-223azacitidine	
CHR-2845	
AbGn-107	
GDC-0349	
GDC-0349	
GDC-0349	
MEGF0444A	
MTL-CEBPA	
MK2206	
MK2206	
MK2206	
MK2206	
MK2206	
MK2206	
MK2206	
MK2206	
MK2206	
MK2206	
EribulinMesylate	
MK-2206	
MK-2206	
MK-2206	
MK-2206	
MK-2206	
AZD6244	
AZD6244	
BXQ-350	
PHA-848125AC	
LDE225	
LDE225	
Mitomycin	ANTINEOPLASTIC ANTIBIOTICS|ANTIGLAUCOMA,OTHER|Other cytotoxic antibiotics|Alkylating Activity|Nucleic Acid Synthesis Inhibitors|Alkylating Drug
EpacadostatINCB024360	
KU-0059436AZD2281PARPinhibitor	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
IPI-504docetaxel	
SCB01A	
MM-398	
5-fluorouracile5-FU	
PCK3145	
PCK3145	
LFA102	
lurbinectedinPM01183	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
Tucatinib	
Tucatinib	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
AromataseInhibitor	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
OMBRABULINAVE8062	
111In-CS-1008CS-1008	
larotaxel	
larotaxel	
larotaxel	
TalimogeneLaherparepvec	
G-202	
FarnesylProteinTransferaseInhibitor	
YY-20394	
TezacitabineFMdC	
SU011248Gemcitabine	
AZD1775	
Anti-angiogenesis	
Radium-223dichlorideXofigoBAY88-8223	
MEK162	
MEK162	
MEK162	
MEK162	
DCC-2618	
LM716	
KW-2450	
KW-2450	
KW-2450	
PVX-410	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
OPB-51602	
LY2603618	
LY2603618	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Valproic	
BAY1895344	
BAY1895344	
BXQ-350	
GEN-1	
Cabazitaxelmg/m2	
Cabazitaxelmg/m2	
D-3263	
D-3263	
D-3263	
Perifosine	
Perifosine	
NM-3	
NM-3	
YL-13027	
AK-105	
APL-501	
Enoblituzumab	
naquotinib	
AZD7762	
AZD7762	
AZD7762	
EM-1421	
EM-1421	
PT-112	
HDM201	
HDM201	
HDM201	
GSK3326595	
GSK3326595	
GSK3326595	
CeramideNanoLiposome	
MORAb-004antibodyTEM1	
Valproic	
MLN4924Docetaxel	
MLN4924PaclitaxelCarboplatin	
MLN4924Gemcitabine	
BYL719	
BYL719	
BYL719	
BYL719	
GSK3368715	
IMGN632	
TKI258	
TKI258	
IMA101	
BelinostatCarboplatinPaclitaxel	
AZD4785	
NeoVax	
panitumumabvemurafenib	
MUC_1	
Alvespimycin	
LFA102	
PTC596	
BKM120	
BKM120	
NKP-1339	
4-Demethyl-4-cholesteryloxycarbonylpenclomedine	
4-Demethyl-4-cholesteryloxycarbonylpenclomedine	
4-Demethyl-4-cholesteryloxycarbonylpenclomedine	
LTT462	
MK-8353	
Selumetinib	
Cetuximab/Gefitiniband/ormonotherapy	
vorinostatSuberoylanilideHydroxamicSAHAPemetrexedCisplatin	
Hu5F9-G4	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Mycophenolatemofetil	
LDE225EtoposideCisplatin	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Tivantinib	
GW003	
GW003	
PDL192	
JAB-3068	
Suberoylanilidehydroxamic	
TCD-717	
TCD-717	
DNIB0600A	
ALN-VSP02	
CUDC-907	
CUDC-907	
CUDC-907	
PF-00299804	
CGC-11047gemcitabine	
CGC-11047docetaxel	
CGC-11047bevacizumab	
CGC-11047	
CGC-11047	
CGC-11047cisplatin	
CGC-110475-flurouracilleucovorin	
CGC-11047sunitinib	
XL092	
Patupilone/EPO906	
Patupilone/EPO906	
PanobinostatCisplatinPemetrexed	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
ABBV-399	
LAE001	
BAY1143572	
RO6839921	
AZD6244	
AZD6244	
AZD3759	
AZD3759	
AZD3759	
AZD3759	
sorafenibFOLFIRI	
ARRY-438162MEK162inhibitor	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Birinapant	
Pembrolizumabmg/kg	
Pembrolizumabmg/kg	
Cisplatinmg/m^2	
Pemetrexedmg/m^2	
Carboplatinmg/mL/min	
Carboplatinmg/mL/min	
Paclitaxelmg/m^2	
Nab-paclitaxelmg/m^2	
Ipilimumabmg/kg	
mg/m^2	
G-CSFpegfilgrastim	
LiposomalIrinotecan	
Paricalcitol	Vitamin D3 Analog|Other anti-parathyroid agents|Enzyme Interactions|VITAMIN D,OTHER
Paricalcitol	Vitamin D3 Analog|Other anti-parathyroid agents|Enzyme Interactions|VITAMIN D,OTHER
rigosertibsodium	
ALX148	
GSK2849330	
89Zr-GSK2849330	
interleukin-4PE38KDELcytotoxin	
OSI-906	
OSI-906	
OSI-906	
Prexasertib	
rigosertibsodium	
PF-06804103	
Sym004	
Sym004	
PaclitaxelPoliglumex	
INC280	
INC280	
INC280	
INC280	
INC280	
ng/kg	
ng/kg	
ng/kg-D1ng/kg	
ng/kg-D1ng/kg	
GBR1302ng/kgng/kgD15,22	
GBR1302ng/kgng/kgD15,22	
GBR1302doses,1200ng/kgD15,22	
GBR1302and/orRP2D	
LDE225+gemcitabine	
AZD8931	
AZD8931	
AZD2811	
AZD2811	
AZD2811	
EOC317	
BYL719	
BYL719	
BYL719	
BYL719	
MNRP1685A	
MNRP1685A	
Dalotuzumab	
PF-03446962	
TucatinibONT-380	
TecemotideL-BLP25	
JAB-3068	
ADG106	
Alisertib	
NivolumabPlinabulin	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Relatlimab	
NGR-hTNF	
IMP4297	
AC0010	
AC0010	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
JNJ-42756493	
APO010	
MEK162mFOLFIRI	
CGM097	
CGM097	
CGM097	
GDC-0980	
GDC-0980	
GDC-0980	
JNJ-74699157	
SM04755	
iNeo-Vac-P01	
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
GDC-0980	
GDC-0980	
GDC-0980	
LErafAON	
BKM120	
BKM120	
CEP-37250/KHK2804	
MDV3100	
MDV3100	
MDV3100	
MDV3100	
DOXIL/CAELYXdoxorubicin	
DOXIL/CAELYXdoxorubicin	
PF-00337210	
PF-00337210	
PF-00337210	
NGR-hTNF	
ASP3026	
ASP3026	
ASP3026	
ASP3026	
RegorafenibStivargaBAY73-4506	
GLPG0187	
GLPG0187	
GLPG0187	
GLPG0187	
GLPG0187	
GLPG0187	
omacetaxinemepesuccinate	
EP2101	
EP2101	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
BGB-290	
BGB-290	
BGB-290	
INCAGN01876	
BMS-754807	
BMS-754807	
BMS-754807	
BMS-754807	
trastuzumabHerceptin®	
MEDI-551	
MEDI-551	
MEDI-551	
ACE-041	
BYL719	
BYL719	
BYL719	
BYL719	
TarcevaerlotinibOSI-774	
PG-11047	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
SCT-I10A	
ABBV-744	
ABBV-744	
ABBV-744	
FPA008	
biologic	
GS-5829	
IMC-RON8	
biologic	
Alpelisib	ANTINEOPLASTIC,OTHER
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Liposomaldoxorubicin	
LEAC-102FOLFOXBevacizumab/Cetuximab	
IMC-A12	
IMC-A12	
IMC-A12	
TAS-102	
TAS-102	
TAS-102	
MPC-3100Hsp90inhibitor	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
18F-AraG	
Carboplatin/etoposide	
IMC-A12	
IMC-A12	
IMC-A12	
AZD4547	
AZD4547	
AZD4547	
LCL161	
LCL161	
LCL161	
LCL161	
tisotumabvedotin	
XL147SAR245408	
OSI-027	
OSI-027	
MK-2206	
MK-2206	
MK-2206	
MK-2206	
MK-2206	
BKM120	
BKM120	
XL281	
XL281	
OBI-833/OBI-821	
PanitumumabTAS-102	
MEDI6383MEDI4736	
IVAC_W_bre1_uID	
IVAC_W_bre1_uID/IVAC_M_uID	
Eribulinmesylate	
Rucaparibcamsylate	
anti-cancer	
SHR7390	
IONIS-STAT3Rx	
BKM120	
BKM120	
PolyPEPI1018Vaccine	
lapatinibesomeprazole	
ziv-aflibercept	Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents
SC-43	
BR55	
MSC-1	
PaclitaxelPTK787	
ARGX-110	
TisotumabVedotin	
AG-013736axitinib	
GSK2256098	
GSK2256098	
GSK2256098	
GSK2256098	
ziv-aflibercept	Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents
ASP8374	
TQB3616	
FamitinibMalate	
MK-2206carboplatinpaclitaxel	
MK-2206docetaxel	
MK-2206erlotinib	
Chemotherapy	
CPI-613	
CPI-613	
CPI-613	
XL147SAR245408	
STA-5312	
STA-5312	
PF-06647020	
PF-06647020	
PF-06647020Avelumab	
NGR-hTNF	
AxitinibAG-013736	
CNTO	
IrosustatBN83495	
CNTO888+DOXIL®/Caelyx®doxorubicinliposome	
CNTO888gemcitabine	
CNTO888Paclitaxelcarboplatin	
CNTO888docetaxel	
BLS_ILS_E710c	
BLS_ILB_710c	
BLS_ILS_E710c	
MM-111	
MM-111	
MM-111	
ST1968	
INCAGN01949	
BAY1179470	
SHR1459	
Simmitecan	
Simmitecan	
Simmitecan	
5-fluorouracilLeucovorinCalcium	
PF-05212384PKI-587	
MGN1703	
MGN1703	
MGN1703	
CT7001	
CT7001	
CT7001	
CT7001	
CT7001fulvestrant	
LY3300054	
Prexasertib	
BIIB022	
BIIB022	
BIIB022	
BIIB022	
TKI258	
TKI258	
GemcitabineCisplatinGemcitabineCarboplatin	
PatupiloneOmeprazole	
PatupiloneMidalzolam	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
X-82	
X-82	
IPI-504	
IPI-504	
SHR-1210Apatinib+Fluzoparib	
HDM201	
HDM201	
HDM201	
ancillary	
AZD5312	
FAZ053	
PDR001	
PDR001	
PDR001	
PDR001	
Sym004	
Sym004	
CKD-516	
CKD-516	
SNS-032	
SNS-032	
tumorpeptidevaccine	
BTP-114	
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
Anti-AndrogenTherapy	
Hormone-ReleasingHormoneLHRH	
LGX818	
LGX818	
LGX818	
BYL719	
BYL719	
BYL719	
BYL719	
OMP-18R5	
GSK2256098	
GSK2256098	
GSK2256098	
GSK2256098	
ASP8374	
PR104	
PR104	
PR104	
OMP-59R5	
ridaforolimus	
ridaforolimus	
BOS172738	
DCVax-Direct	
TAK-700	
TAK-700	
Chiauranib	
RX-5902	
Trastuzumabnon-pegylatedliposomaldoxorubicin	
NGR-hTNF	
SHR-A1403	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Capivasertib	
Danvatirsen	
Oleclumab	
Ad5-SGE-REIC/Dkk3	
BEY1107	
TEW-7197	
TEW-7197	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
I-131-CLR1404	
Glumetinib	
Glumetinib	
Glumetinib	
MVT-1075	
MVT-5873	
ORIC-101	
Xtandi	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
BGJ398	
BGJ398	
BGJ398	
BGJ398	
PR-104	
PR-104	
PR-104	
RXC004	
SCT200	
PR-104	
PR-104	
PR-104	
gemcitabinehydrochloride	
Ulixertinib	
COM701	
COM701OpdivoNivolumab	
MEDI1191	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
AEE788	
AEE788	
GDC-0941	
GDC-0941	
XL147SAR245408	
XL765SAR245409	
letrozoleFemara	
BAY94-9343	
exatecanmesylate	
GSK2820151	
CHR-3996	
CHR-3996	
CHR-3996	
MEDI5395	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
RegorafenibStivargaBAY73-4506	
Escalation	
Anti-OX40Antibody	
TLR9SD-101	
Rexin-G	
AZD5363	
AZD5363	
AZD5363	
INCB081776	
ATI-1123docetaxel	
ME-143	
peptidevaccineGM-CSF	
Intraperitonealdocetaxel	
'SMT-NKallogeneic	
PembrolizumabKeytruda	
MEK162RAF265	
NeoTCR-P1therapy	
BAY86-9766+Gemcitabine	
CV787CG7870	
intravenousdocetaxelintraperitonealoxaliplatin	
intravenousoxaliplatinintraperitonealdocetaxel	
GPX-100	
GPX-100	
GPX-100	
GPX-100	
volasertib	
G1T48	
CM4307	
CM4307	
CM4307	
AG-013726	
AG-013736axitinib	
INCSHR01210	
Ricolinostat	
triapine	
triapine	
MORAb-009	
SEA-CD40monotherapy	
SEA-CD40monotherapy	
AZD4877	
AZD4877	
AZD4877	
TP-3654	
TP-3654	
TP-3654	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
salmonellaVNP20009	
Gemcitabine-ReleasingIntravesicalGemRIS/TAR-200	
NivolumabOpdivo	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
gemcitabinesplit-dosecisplatinEverolimusRAD001	
Gemcitabine-ReleasingIntravesicalGemRIS/TAR-200	
SNS-314	
SNS-314	
SNS-314	
MK-1248	
Gemcitabine-ReleasingIntravesicalGemRIS/TAR-200	
RAD001AMG479	
DJ-927	
DJ-927	
DJ-927	
PM01183	
PM01183	
TG6002	
Flucytosine5-FCAncotil	
lurbinectedinPM01183	
G3139OblimersensodiumBcl-2antisenseoligonucleotide	
alpelisib	ANTINEOPLASTIC,OTHER
AVB-S6-500	
liposomaldoxorubicin	
NexavarSorafenibBAY43-9006	
SV-BR-1-GM	
InterferonInoculation	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Abiraterone/Prednisone	
irinotecanhydrochloride	
KN035	
KN035	
TLC178	
BAY1834942	
MSC2156119J	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
CDX-0158KTN-0158	
OMP-59R5	
APX3330	
salmonellaVNP20009	
ceftriaxonesodium	
idronoxil	
NilotinibImatinib	
budesonide/formoterolfumaratedihydrate	
methylation	
genomichybridization	
microarray	
triapine	
triapine	
AT13387	
AT13387	
AT13387	
IMF-001	
ABT-700	
ABT-700	
sunitinibrapamycin	
TP-0184	
BAY1436032	
5-Fluorouracil5-FU	
lurbinectedinPM01183	
MSC2363318A	
MSC2363318A	
MSC2363318ATrastuzumab	
MSC2363318ATamoxifen	
TRC102	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
RecentinCediranib	
TAK-901	
TAK-901	
TAK-901	
Epacadostat	
INCB057643	
INCB059872	
anti-EGFRantibody	
VELCADEbortezomib	
SHR-1316	
darinaparsin	
darinaparsin	
RXDX-105	
LYC-55716	
SHR7390	
SHR-1210	
SHR3162	
CT-2106	
Folinic	
5-FUfluorouracil	
IBI308	
IBI308	
ALKS	
MPC-6827	
MPC-6827	
FOLFOX	
FOLFOX	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
IrinotecanCetuximab	
ABT-165	
ABBV-181	
ABBV-181	
GSK1120212BDMSO	
GSK1120212BDMSO	
forodesinehydrochloride	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
ME-344	
ME-344	
ME-344	
CP-4126	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
RX-3117	
TAS-116	
TAS-116	
TAS-116	
AG-120	
PTC596	
AV-203	
AMP-224	
AMP-224	
AMP-224	
Albumin-boundpaclitaxel	
Genexol-PM	
P16_37-63peptideMontanide®ISA-51	
P16_37-63peptideMontanide®ISA-51	
JNJ-63898081	
Relatlimab	
BMS-986213	
RBN-2397	
irinotecanhydrochloride	
leucovorincalcium	
Vectibix®panitumumab	
ONT-10	
Genz-64428228-day	
Genz-64428221-day	
palifermin	Keratinocyte Growth Factor Receptor Agonists|Mucocutaneous Epithelial Cell Growth Factor|Detoxifying agents for antineoplastic treatment|HORMONES/SYNTHETICS/MODIFIERS,OTHER
EMD525797	
SunitinibPemetrexedCisplatinCarboplatin	
ONT-10	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
BMX-001	
BMX-001	
BMX-001	
Blood-stageP.vivax	
SorafenibNexavarBAY43-9006	
LY2603618	
LY2603618	
NKTR-214	
RogaratinibBAY1163877	
CopanlisibBAY80-6946	
chemotherapy	
M6620	
RovalpituzumabTesirine	
ABBV-181	
ABBV-181	
Defactinib	
BMS-754807	
BMS-754807	
BMS-754807	
BMS-754807	
MGD019	
CT-322	
GSK923295	
GSK923295	
OTSGC-A24	
mg/kgPaclitaxelTrastuzumab	
mg/kgCapecitabineLapatinib	
mgkgPaclitaxelTrastuzumab	
mg/kgCapecitabineLapatinib	
43-9006	
HE3235	
HE3235	
HE3235	
XL147SAR245408	
vaccine	
autologoustumorvaccine	
leucovorincalcium	
AlphaMedix	
Regimen	
IMP321	
IMP321	
IMP321	
IMP321	
IMP321	
TRC253	
CK-301cosibelimab	
panHer	
FN-1501	
MEDI9090	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
INCAGN01876	
Epacadostat	
YS-0N-001	
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
LY3023414	
LY3023414	
LY3023414	
IT-141	
ZW49	
CUDC-101	
CUDC-101	
CUDC-101	
TP-1287	
EribulinMesylate	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
STA-9090	
STA-9090	
Theliatinib	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Neoantigenvaccine	
CHR-2797tosedostat	
DurvalumabTremelimumabTherapy	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
TRX-818	
SHR6390	
LetrozoleanastrozoleFulvestrant	
Anti-RANKLAntibody	
CGX1321	
ABTL0812	
ABTL0812	
ABTL0812	
ABTL0812	
AUY922	
AUY922	
AUY922	
AUY922	
AUY922	
ABBV-927	
ABBV-181	
ABBV-181	
PremetrexedAlimta	
veliparibABT-888	
OblimersenGenasense	
SB-743921	
SB-743921	
SB-743921	
SB-743921	
SB-743921	
TR1801-ADC	
AldoxorubicinHydrochloride	
ALT-803	
ALT-803	
ETBX-011	
ETBX-021	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Rexin-G	
Ad/PNP	
MEDI5752	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
KTN3379	
LY2801653	
LY2801653	
LY2801653	
LY2801653	
INCAGN01876	
GSK3052230	
GSK3052230	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
IntermittentAZD5363	
DSP-0337	
CYC065	
CYC065	
CYC065	
CYC065	
CombretastatinCA4P	
BevacizumabAvastin	
prednisone/prednisolonedexamethasone	
durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
AZD8931	
AZD8931	
ABBV-428	
SYD985trastuzumabvc-seco-DUBA	
Omacetaxine	Protein Synthesis Inhibitors
MK-7684	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
ISA101/ISA101b	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
PF-04449913	
PF-04449913	
PF-04449913	
ZN-c5	
SGT-53	
SHR6390	
sulfatinib	
AZD8055	
AZD8055	
AZD8055	
AZD8055	
ARRY-382cFMSinhibitor	
OMP-21M18	
OMP-21M18	
CV9103	
Galunisertib	
GDC-0032	
GDC-0032	
SM-88	
MK-4830	
BKM120	
BKM120	
Modufolin	
ZW25	
BMS-986016	
Galunisertib	
LY3405105	
BMS-813160	
5-fluorouracil5-FU	
DSP-0509	
GDC-0941	
GDC-0941	
PRN1371	
PRN1371	
PRN1371	
INO-3112	
BZL101	
CEP-9722	
CEP-9722	
CEP-9722	
CEP-9722	
CEP-9722	
MK-0482	
lurbinectedinPM01183	
IMMU-107hPAM4	
CPI-444	
CPI-444atezolizumab	
liposomaldoxorubicin	
LCL161	
LCL161	
LCL161	
LCL161	
6R-MTHFmg/m2	
Levoleucovorinmg/m2	
6R-MTHFmg/m2	
Levoleucovorinmg/m2	
I-131-CLR1404	
CMB305	
G100	
Metronomic	
GSK1363089XL880	
LY3415244	
ICP-105	
Cetuximaberbitux®	
Fruquintinib	
Fruquintinib	
Fruquintinib	
TAS-102	
TAS-102	
TAS-102	
thioureidobutyronitrile	
SPL-108	
LY3200882	
LY3300054	
F-AraG	
Volitinib	
AO-176	
MIW815	
PDR001	
PDR001	
PDR001	
PDR001	
OMP-52M51	
OMP-52M51	
OMP-52M51	
Radium-223Xofigo®BAY88-8223	
ICP-192	
PembrolizumabPre-Resection	
PembrolizumabPost-Resection	
TTX-030	
AZD5363paclitaxel	
AZD5363whenpaclitaxel	
RO6874813	
SNX-5422MesylateHsp90inhibitor	
SB-715992	
SB-715992	
Atezolizumab1200	
SacituzumabGovitecan	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
NOV1601CHC2014	
LOAd703	
MP0274	
ARRY-334543EGFR/ErbB2inhibitor	
Docetaxelmitoticinhibitorintravenous	
subcutaneous	
VolitinibHMPL-504	
INC280	
INC280	
INC280	
INC280	
INC280	
Orteronel	
RiMO-301	
enfortumabvedotin	
RovalpituzumabtesirineSC16LD6.5	
ARRY-334543EGFR/ErbB2inhibitor	
E7389-LF	
TAS-102	
TAS-102	
TAS-102	
LZM009anti-PD-1antibody	
CC-90011	
RM-1929	
BMS-833923XL139	
DTA-H19	
perifosine	
perifosine	
Xentuzumab	
Xentuzumab	
Xentuzumab	
Xentuzumab	
Xentuzumab	
Xentuzumab	
NLG802	
NKTR-214	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
TRC105	
ARRY-334543EGFR/ErbB2inhibitor	
Capecitabine5-fluorouracilprodrug	
Emactuzumab	
RO7009789	
DLYE5953A	
SAR439859	
INVAC-1	
PazopanibGW786034	
pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
MGCD265	
MGCD265	
MGCD265	
MGCD265	
MGCD265	
MK-4280	
LeucovorinCalciumFolinate	
Fluorouracil5-FU	
MK-4280A	
CPI-100	
HB002.1T	
VT1021	
JNJ-63723283	
Erdafitinib	ANTINEOPLASTIC,OTHER
Erdafitinib	ANTINEOPLASTIC,OTHER
BAY1163877	
SHR-1603	
Imatinibmesilate	
PTX-100	
BIBW	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
BIBW	
mg/kgOnartuzumabMetMAb	
mg/kgOnartuzumabMetMAb	
mg/kgOnartuzumabMetMAb	
MEDI0562	
MEDI0562	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
AtezolizumabMPDL3280Aanti-programmeddeath-ligandPD-L1antibody	
Ipatasertib	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
DV281	
DV281RP2D	
Anti-PD-1Inhibitor	
intravenous	
Oraxol	
Blood-stageP.vivax	
RO7121661	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
HL-085	
ALT-803	
ALT-803	
MOXR0916	
D07001-softgel	
GL-ONC1	
Oraxol	
matuzumab	
matuzumab	
CS1003	
MT110	
BAY1082439	
AtezolizumabMPDL3280Aanti-programmeddeath-ligandPD-L1antibody	
MOXR0916humanizedanti-OX40antibody	
ZSTK474	
ZSTK474	
ZSTK474	
ZSTK474	
XmAb®23104	
MEHD7945A	
MEHD7945A	
MEHD7945A	
MEHD7945A	
BMS-690514	
BMS-690514	
BMS-690514	
14C-LabeledVemurafenib	
PS-341Bortezomib	
prexasertib	
ralimetinib	
Dabigatranetexilate	
BAY1841788darolutamide	
ARQ197	
OBP-801	
WXFL10030390	
Mitomycin	ANTINEOPLASTIC ANTIBIOTICS|ANTIGLAUCOMA,OTHER|Other cytotoxic antibiotics|Alkylating Activity|Nucleic Acid Synthesis Inhibitors|Alkylating Drug
Chemophase	
BEZ235Paclitaxel	
RO5458640	
OXi4503	
OXi4503	
OXi4503	
OXi4503	
OXi4503	
enadenotucirev	
EM-1421	
EM-1421	
LPM3480226	
pamiparib	
pamiparib	
pamiparib	
pamiparib	
pamiparib	
pamiparib	
IPN60090	
PS101Ultraescalation	
PS101Ultra	
Kanitinib	
ERY974	
Zr-BI	
Trilaciclib	
14C-labeledpoziotinib	
SB-715992	
SB-715992	
IM19CAR-T	
CO-1.01mg/mL	
CO-1.01mg/mL	
AZD1775	
hPV19	
MM-151	
MM-151irinotecan	
CCT301-59	
ABBV-321	
peptidevaccineGM-CSF	
CS1001	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
CS-7017	
CS-7017	
CS-7017	
AT13387	
AT13387	
AT13387	
Volasertibd1q3w	
Volasertibd1q3w	
Volasertibd1q3w	
KN046	
LY3381916	
LY3300054	
VinorelbineTartrate	
BevacizumabbiosimilarBEVZ92	
Avastin®bevacizumab	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
ZSTK474	
ZSTK474	
ZSTK474	
ZSTK474	
PQR309	
PQR309	
BMS-754807	
BMS-754807	
BMS-754807	
BMS-754807	
Myocet	
GDC-0919	
Vaccine	
HLX22	
volasertib	
CX-3543	
BIBW	
Vinorelbinemg/m²	
Vinorelbinemg/m²	
Vinorelbinemg/m²	
Hemay020	
AGEN2034	
AGEN2034	
BMS-906024	
BMS-906024	
BMS-906024	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
RO5045337	
RO5045337	
RO5045337	
RO7198457	
LY3127804	
Epitinib	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
HC-1119	
TQB2450	
Anlotinib	
Anlotinib	
Anlotinib	
FF21101	
BTRC4017A	
ARRY-142886inhibitor	
CopanlisibBAY80-6946	
AsiDNA	
HuMax-IL8	
RO5503781	
RO5503781	
RO5503781	
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
BMS-986205	
BMS-986205	
BGB-283	
MORAb-004	
TEW-7197	
TEW-7197	
PF-04691502	
PF-04691502	
PF-04691502	
PEP02	
Dalotuzumab	
Amatuximab	
CCS1477	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
LY3321367	
LY3300054	
Ridaforolimus	
Ridaforolimus	
TRC105Bevacizumab	
CKD-810Taxotere	
Taxotere®	
Taxotere®	
HospiraDocetaxel	
HM95573	
BirinapantTL32711	
MORAb-009	
5,10-methylenetetrahydrofolate	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
HC1119	
BMS-907351XL184	
LY2523355	
LY2523355	
Lucitanib	
PF-03732010	
PF-03732010	
INCB024360	
ASP4132	
tivozanib	
MEDI-522	
GS-1423	
RO6895882	
MK-7162	
Ispinesib	
Ispinesib	
SHR-1210	
OKI-179	
KITE-718	
XL820	
U3-1287	
U3-1287	
TAK-285Escalation	
TAK-285	
TAK-285	
TAK-285	
AtezolizumabTECENTRIQ	
Vanucizumab	
Vanucizumab	
SBP-101	
BAY79-4620	
BAY79-4620	
CEP-11981inhibitor	
NPC-1C/NEO-102	
BMS-906024	
BMS-906024	
BMS-906024	
Docetaxel-PNP	
Vx-006	
Vx-006	
Vx-006	
Vx-006	
CA-170	
Ixabepilonemg/d	
Ixabepilonemg/d	
Ixabepilonemg/d	
Ixabepilonemg/d	
Ixabepilonemg/d	
Ixabepilonemg/d	
Ixabepilonefamotidine	
TBI-1401HF10	
lapatinibdocetaxeltrastuzumab	
Docetaxeltrastuzumab	
RMC-4630	
Co-ArgI-PEG	
RegorafenibStivargaBAY73-4506	
IMC-18F1	
IMC-18F1	
IMC-18F1	
CopanlisibRefametinibBAY86-9766	
SAR405838	
SAR405838	
SAR405838	
SAR405838	
RG1507	
RG1507	
AUY922	
AUY922	
AUY922	
AUY922	
AUY922	
RC48-ADC	
RO5212054	
AVB-S6-500	
GDC-0810	
GDC-0810	
ThermoDoxHyperthermia	
Simmitinib	
Itacitinib	
Epacadostat	
INCB050465	
HS-10241	
Apatinib	
Apatinib	
Apatinib	
cediranibRECENTINAZD2171	
BPI-16350	
LHC165	
PDR001	
PDR001	
PDR001	
PDR001	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Lovaza	ANTILIPEMIC AGENTS
Lovaza	ANTILIPEMIC AGENTS
ALT-803	
ALT-803	
ETBX-011	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
Ipatasertib	
TAPA-pulsedvaccine	
NaCl	ELECTROLYTES/MINERALS,COMBINATIONS|RESPIRATORY AGENTS,OTHER|Electrolyte solutions|ELECTROLYTES/MINERALS,OTHER|IV SOLUTIONS WITHOUT ELECTROLYTES|Salt solutions|EYE WASHES/LUBRICANTS|AMINO ACIDS/PROTEINS,PARENTERAL,WITH ADDED ELECTROLYTES|HYPEROSMOTIC LAXATIVES|Sodium|Acid-Base Activity|AMINO ACIDS/PROTEINS,PARENTERAL,WITHOUT ADDED ELECTROLYTES|NASAL AND THROAT,TOPICAL,OTHER|IV SOLUTIONS WITH ELECTROLYTES|DERMATOLOGICALS,TOPICAL OTHER|PHARMACEUTICAL AIDS/REAGENTS|PERITONEAL DIALYSIS SOLUTIONS|OPHTHALMICS,OTHER|LAXATIVES,OTHER|Electrolyte Activity|SODIUM|IRRIGATION SOLUTIONS
BAY80-6964	
AZD8055	
AZD8055	
AZD8055	
AZD8055	
BGB-283	
BMS-986299	
RO5429083	
ObatoclaxmesylateGX15-070MS	
BI-6727	
repotrectinibTPX-0005	
EOS100850	
XL999	
XL999	
XL999	
NMS-1286937	
BiCAR-NKROBO1CAR-NK	
HS-410	
RO5045337	
RO5045337	
RO5045337	
MSB0011359C	
XmAb®22841	
PembrolizumabKeytruda®	
Abiraterone	Other hormone antagonists and related agents|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 17A1 Inhibitors|ANTINEOPLASTIC HORMONES|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 17A1 Inhibitor
RO4987655	
RO4987655	
RO4987655	
RO4987655	
RG547	
ZIO-101	
HLX04	
HLX10	
MRTX849	
RG4733	
RO5126766	
RO5126766	
itacitinib	
GDC-0575	
beta-glucan	
beta-glucan	
beta-glucan	
RG1530	
pertuzumabPerjeta	
trastuzumabemtansineKadcyla	
BAY1000394	
BAY1000394	
BAY1000394	
GDC-0919	
MK-4166	
carboplatinSU011248sunitinibpaclitaxel	
68-Ga	
68-GaPSMA11	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
CPI-200	
TQB2450	
Anlotinib	
Anlotinib	
Anlotinib	
E7389carboplatin	
E7389carboplatin	
E7389+carboplatin	
INCAGN01949	
BYL719	
BYL719	
BYL719	
BYL719	
APG-115	
STA-4783/paclitaxel	
BIBW	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Ipatasertib	
Oratecan	
CS1001	
PEG20	
CS-1008	
CS-1008	
CS-1008	
SorafenibNexavarBAY43-9006	
RG1507	
RG1507	
RoniciclibBAY1000394	
PEP02	
Cabiralizumab	
Urelumab	
Amphinex	
Gentuximab	
norethindroneethinylestradiol	
ABTL0812	
ABTL0812	
ABTL0812	
ABTL0812	
Gemcitabinenab-paclitaxel	
AZD4635	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Oleclumab	
C-0501	
ZIO-101Darinaparsin	
GDC-0994	
GDC-0994	
Idasanutlin	
MK0731	
MK0731	
MK0731	
MK0731	
IC83/LY2603618	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
WX-UK1Capecitabine	
SP-2577Seclidemstat	
panobinostatLBH589	
131I-F16SIPRadioimmunotherapy	
U3-1287AMG888	
AV0113DC-CIT	
KRN951	
KRN951	
HL-085	
PaclitaxelCarboplatinCP-870,893	
Debio	
abnobaVISCUMFraxini	
LarotrectinibVitrakviBAY2757556	
bacTRL-IL-12	
MSB2311	
FF-10832GemcitabineLiposome	
YM155	
YM155	
YM155	
veliparibABT-888	
hGM-CSF	
IBI308	
IBI308	
IBI308\Cisplatinum\Pemetrexed	
IBI308\cisplatin\gemcitabine	
IBI308\oxaliplatin\capecitabine	
IBI308\etoposide\cisplatin	
IBI308\irinotecan\5-FU	
SM88	
SM88	
alpha1H	
Merestinib	
ImmunotherapyGM-CSFvaccine	
AV-299	
AV-299erlotinib	
NV1020	
VAL-083Dianhydrogalactitol	
RO5045337	
RO5045337	
RO5045337	
PM060184	
PM060184	
PM060184	
MEDI9447oleclumab	
BGB-A317	
MEDI-573	
SGN-CD228A	
L-DOS47	
IBI101	
Sintilimab	
Sintilimab	
Sintilimab	
GAd-209-FSP	
MVA-209-FSP	
GAd-209-FSP	
MVA-209-FSP	
SHR-1702	
Camrelizumab	
Camrelizumab	
Camrelizumab	
LY3039478	
LY3039478	
LY3039478	
Trastuzumabemtansine	
Emactuzumab	
LY2603618	
LY2603618	
EF-022VitaminProteinMacrophageActivator	
isavuconazoniumintravenous	
isavuconazonium	ANTIFUNGALS
isavuconazonium	ANTIFUNGALS
donafenibtosilate	
CC-90010	
SOM230C	
FF-10850TopotecanLiposome	
SH-1028	
MP0310	
BSI-201iniparib	
MEDI-575	
KPT-330	
KPT-330	
177Lu-PSMA-R2	
ImmunotherapyGM-CSFvaccine	
MEK162	
MEK162	
MEK162	
MEK162	
Pexidartinib	
Debio1347CH5183284	
CBP501	
CBP501	
CBP501	
Lucitanib	
Sacituzumabgovitecan	
BAT8003	
Roniciclib	
ItraconazoleSporanox	
AnlotinibHydrochloride	
GWN323	
PDR001	
PDR001	
PDR001	
PDR001	
CabazitaxelXRP6258	
PM01183	
PM01183	
Selicrelumab	
Selicrelumab	
IBI310	
Sintilimab	
Sintilimab	
Sintilimab	
GB226	
mPEG-r-crisantaspase	
RO5479599	
zirconium-89-labeledRO5479599	
HTI-1090	
MidazolamHydrochloride	
Chlorogenic	
RO5083945	
RO5083945	
MGD009	
MGA012	
MGA012	
MGA012	
MGA012	
donafenibtosilate	
TKI258	
TKI258	
Oradoxel	
RO6958688	
RO6958688	
RO6958688	
RO6958688	
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
FG-3019	
FG-3019	
RO6958688	
RO6958688	
RO6958688	
RO6958688	
Andecaliximab	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
ABT-869	
ABT-869	
ALT-803	
ALT-803	
ETBX-011	
GI-4000	
GI-4000	
haNK	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
lovaza	ANTILIPEMIC AGENTS
lovaza	ANTILIPEMIC AGENTS
ODM-208	
NER1006	
Moviprep	Vitamin C|Unknown Cellular or Molecular Interaction|HYPEROSMOTIC LAXATIVES|Other ophthalmologicals|Electrolyte Activity|Ascorbic acid (vitamin C), plain|Salt solutions|Free Radical Scavenging Activity|Enzyme Interactions|Sodium|Acid-Base Activity|Organic acids|Osmotic Laxative|Osmotically acting laxatives|Electrolyte solutions|Potassium|Osmotic Activity
BGB-A1217	
Tislelizumab	
Tislelizumab	
NIRFLI	
Alkotinib	
GatipotuzumabTomuzotuximab	
PLX3397	
PLX3397	
PLX3397	
NanoliposomalIrinotecan	
IMMU-130	
dalotuzumab	
ridaforolimus	
ridaforolimus	
indibulin	
indibulin	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
OSI-906	
OSI-906	
OSI-906	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
IM156	
TKI258dovitinib	
AxitinibPaclitaxelCarboplatin	
AxitinibPaclitaxelCarboplatin	
AxitinibPaclitaxelCarboplatin	
AxitinibPaclitaxel	
AxitinibDocetaxelCarboplatin	
AxitinibDocetaxel	
AxitinibCapecitabine	
AxitinibCapecitabine	
AxitinibGemcitabineCisplatin	
AxitinibPemetrexedCisplatin	
INCMGA00012	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
MBG453	
PDR001	
PDR001	
PDR001	
PDR001	
AC220	
AC220	
AC220	
SNS-595	
SNS-595	
DN1508052-01	
Oraxol	
SAR245408XL147	
MSC1936369B	
MSC1936369B	
MSC1936369B	
MSC1936369B	
C31510	
ODM-204	
CH5132799	
CH5132799	
CH5132799	
CH5132799	
CH5132799	
-pamiparib	
-pamiparib	
Ridaforolimus	
Ridaforolimus	
ZEN003694	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
ADCT-601	
Imprime	
Isatuximab	
Selicrelumab	
Selicrelumab	
HLX20	
Idasanutlin	
Idasanutlin	
Idasanutlin	
SHR-1316	
PEP503	
GLS-010	
HTI-1066	
HTI-1066	
HTI-1066	
HTI-1066	
LY573636-sodium	
LiposomalDoxorubicin	
FruquintinibHMPL-013	
IMO-2055	
IMO-2055	
68Ga-PSMA-R2	
N-803	
ETBX-011	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
anticancerIC01	
BMS-986301	
PF-00299804	
BYL719	
BYL719	
BYL719	
BYL719	
Tazemetostat	
Tazemetostat	
ABI-009	
CergutuzumabAmunaleukin	
Tivantinib	
Epacadostat	
Epacadostat	
Epacadostat	
Cisplatinmg/m^2	
Pemetrexedmg/m^2	
Paclitaxelmg/m^2	
CarboplatinAUC6	
TAS-102	
TAS-102	
TAS-102	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
GDC-0068	
GDC-0068	
SNS-595	
SNS-595	
paclitaxelcarboplatin	
carboplatinetoposide	
gemcitabinecarboplatin	
nab-paclitaxelpaclitaxel-albumincarboplatin	
oxaliplatin5-fluorouracilleucovorincalcium	
durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
nab-paclitaxelpaclitaxel-albumingemcitabine	
cisplatin5-fluorouracil	
XNW7201	
CS3006	
TAK-593	
TAK-593	
TAK-593	
TAK-593	
SitravatinibTislelizumab	
CPX-POM	
Comparator	
Comparator	
ImmunotherapyGM-CSFvaccine	
XL999	
XL999	
XL999	
ALIMTAEpirubicin	
Carboplatin/Paclitaxel/MEDI-575	
Carboplatin/Paclitaxel	
Lucitanib	
KA2507	
Dinaciclib	
Dinaciclib	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
5-Fluorouracil5-FU	
Lovaza	ANTILIPEMIC AGENTS
Lovaza	ANTILIPEMIC AGENTS
ALT-803	
ALT-803	
ETBX-011	
ETBX-021	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
E7016	
CNF2024	
MotexafinGadolinium	
ombrabulinAVE8062	
BIIB015	
GDC-0980	
GDC-0980	
GDC-0980	
mFOLFOX6	
fruquintinib+paclitaxel	
MEK162	
MEK162	
MEK162	
MEK162	
MK-1308	
BC-819	
ImmunotherapyGM-CSFvaccine	
Urelumab	
LGX818	
LGX818	
LGX818	
EpothiloneKOS-862	
KN046	
BacilleCalmette-Guérin	
AGEN1884AGEN2034	
SM08502	
LXI-15029	
LXI-15029+Exemestane	
MLN0128	
MLN0128	
MLN0128	
GSK2110183carboplatinpaclitaxel	
CG200745	
CG200745	
CG200745	
CG200745	
CG200745	
Lipegfilgrastim	Colony stimulating factors
ACY-241	
NC-6004	
PlitidepsinSorafenib	
GemcitabinePlitidepsin	
X-396ensartinib	
NYESO-1c259	
rhuMAb	
Radium-223dichlorideXofigoBAY88-8223	
GDC-0917	
GDC-0917	
GDC-0917	
CDX-1401ResiquimodPoly-ICLC	
CDX-1401	
INCB059872	
retinoicATRA	
JNJ-63723283	
JNJ-63723283	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
LY2603618	
LY2603618	
DZD9008	
AG-270	
irinotecan3-week	
DKY709	
PDR001	
PDR001	
PDR001	
PDR001	
BiCAR-NK/TROBO1CAR-NK/T	
BKM120	
BKM120	
hexaminolevulinate	
hexaminolevulinate	
BCG+ALT-803	
MNRP1685A	
MNRP1685A	
BAY94-9392	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
ALT-803	
ALT-803	
ETBX-011	
GI-4000	
GI-4000	
Ga-68P16-093PET/CT	
V3-P	
CabazitaxelXRP6258	
GDC-0623	
GDC-0623	
GDC-0623	
GDC-0623	
ABT-806	
ABT-806	
ABT-806	
PSMA-CART	
Anlotinib14C-labeledAnlotinib	
TAK-931	
TAK-931	
TAK-931	
cabazitaxelXRP6258	
ALT-803	
ALT-803	
ETBX-011	
ETBX-021	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
AS1411	
AS1411	
AS1411	
PLX038	
SimmitecanHydrochloride	
UrelumabBMS-663513	
CabazitaxelXRP6258	
BBI608	
BMS-936558MDX-1106	
MEN1309	
TNO155	
TAS-114	
TrastuzumabderuxtecanDS-8201a	
Brivanib	
Brivanib	
GDC-0980	
GDC-0980	
GDC-0980	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
XmAb20717	
Andes-1537	
CUDC-907	
CUDC-907	
CUDC-907	
JNJ-64457107	
JNJ-64457107	
MT-5111	
Velcadebortezomib	
MINT1526A	
ZIO-201-Tdoxorubicin	
ABI-009nab-rapamycinalbumin-boundrapamycin	
OPB-31121	
OPB-31121	
PLX9486	
PLX3397	
PLX3397	
PLX3397	
BKM120Olaparib	
BYL719Olaparib	
ALT-803	
ALT-803	
ETBX-011	
GI-4000	
GI-4000	
haNK	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
lovaza	ANTILIPEMIC AGENTS
lovaza	ANTILIPEMIC AGENTS
Cytokine-induced	
ARN-509	
ARN-509	
ARN-509	
ARN-509	
ARN-509	
ARN-509	
MycograbDocetaxel	
TAK-700	
TAK-700	
YE-NEO-001	
CP-4055	
CP-4055	
linifanib	
Abiraterone	Other hormone antagonists and related agents|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 17A1 Inhibitors|ANTINEOPLASTIC HORMONES|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 17A1 Inhibitor
Apitolisib	
Ipatasertib	
RAD001CetuximabIrinotecan	
ONCOS-102	
OMP-305B83	
OMP-305B83	
OMP-305B83	
OMP-305B83	
OMP-305B83	
Osteodex	
CarboplatinPaclitaxel	
Galunisertib	
Tanespimycin	
Tanespimycin	
AZD1775	
MEDI-522	
cabazitaxelXRP6258	
CX-188	
MetMAb	
mg/kg	
mg/kg	
mg/kg	
PF-03814735	
PF-03814735	
PF-03814735	
PF-03814735	
pyrotinib	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
OBI-888	
Alisertib	
BCD-135	
Ad-E6E7	
MG1-E6E7	
IGF-Methotrexate	
SAR439459	
CemiplimabREGN2810	
VeliparibABT-888	
paclitaxelgemcitabinelapatinib	
GL-ONC1	
vorinostatMK0683	
TAK-931	
TAK-931	
TAK-931	
BIIB021	
BIIB021	
BIIB021	
BIIB021	
BIIB0121	
TAK-981	
DCVac/PCa	
RO5045337	
RO5045337	
RO5045337	
Merestinib	
BMS-986012	
TAK-228	
RO6870810	
ABT-806	
ABT-806	
ABT-806	
ASP3026	
ASP3026	
ASP3026	
ASP3026	
selumetinib	
ASG-5ME	
ASG-5ME	
Atu027	
Atu027	
Atu027	
AZD0156	
AZD0156	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Folinic	
T-1101Tosylate	
Norethindrone/ethinylestradiol	
PLX8394	
PLX8394	
PLX8394	
PLX8394	
PT-112	
Linifanib	
Alisertib	
Ridaforolimus	
Ridaforolimus	
Ridaforolimus	
Ridaforolimus	
IRX4204	
ZD6474vandetanib	
IniparibSAR240550BSI-201	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
MK-2206	
MK-2206	
MK-2206	
MK-2206	
MK-2206	
NimotuzumabTheraCIMh-R3	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
SAR408701	
SAR408701	
SAR408701	
SAR408701	
HSV-TK	
Claudiximab	
NPC-1C	
REGN5678	
Cemiplimab	ANTINEOPLASTIC,OTHER
Cemiplimab	ANTINEOPLASTIC,OTHER
RRx-001	
RRx-001	
RRx-001	
TRQ15-01	
veliparibABT-888	
SB-485232	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
NHS-IL12	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
NHS-IL12	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
VERU-111	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
HM781-36B	
HM781-36B	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Centrum	
BMS-908662	
BMS-908662	
BMS-908662	
TAK-788	
BIIB028	
BIIB028	
BIIB028	
BIIB028	
CS1003antibody	
HyperAcute-ProstateVaccine	
TJ011133	
AZD1390	
TAK-701	
LB-100	
LB-100	
LB-100	
LB-100	
ABT-806	
ABT-806	
ABT-806	
ABT-806i	
HGS1029	
HGS1029	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
GDC-0941	
GDC-0941	
durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
tremelimumabdurvalumab	
Paclitaxel+HM30181	
4SC-205	
APG-2449	
OmbrabulinAVE8062	
ABT-348carboplatin	
ABT-348docetaxel	
RO5509554	
RO5509554	
RO5509554	
L-malate	
BVAC-C	
NC-4016	
TAS-102	
TAS-102	
TAS-102	
VMD-928300-mg	
MEDI0680	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
CD3/HER2bispecificantibody	
Gemcitabine-ReleasingIntravesicalGemRIS/TAR-200	
ReposMBZ	
XY0206	
Motesanibdiphosphate	
ONO-7475	
ONO-7475ONO-4538	
AnetumabravtansineBAY94-9343	
TRC105	
Temodar®	
Temodar®therapy	
ACTR	
E7820	
E7820	
E7820	
Selumetinib	
CP-868,596	
Hemay102	
RegorafenibStivargaBAY73-4506	
ONO-4578	
HyperAcute-PancreaticVaccine	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Relacorilant	
Relacorilant	
SH-1028	
AlloStim-7	
AlloStim-7	
AlloStim8AlloStim-9	
BIIB021	
BIIB021	
BIIB021	
BIIB021	
dalotuzumab	
Z-360	
Z-360	
Z-360	
therapyS81694paclitaxel	
therapyS81694paclitaxel	
MLN2704antibodyMLN591	
IPI-926gemcitabine	
Debio	
MK-5108	
MK-5108	
MK-5108	
MK-5108	
MK-5108	
CDX1307	
Lipotecan	
TTI-101	
KN035	
KN035	
Temsirolimuscapecitabine	
FS102	
VB10.16Immunotherapyvaccine	
TLK286	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
DurvalumabTremelimumab	
Y-90TherapySIRT	
StereotacticTherapySBRT	
HyperAcute®-RenalImmunotherapy	
Alisertib	
ADXS-NEO	
CUDC-101	
CUDC-101	
CUDC-101	
SY-1365	
TLK286	
SB-485232	
ZSP1241	
LY3023414	
LY3023414	
LY3023414	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
KN026KN046	
DS-3078a	
BPI-15086	
Anti-MUC1CAR-T	
PD-1	
CAR-TPD-1	
CP-675,206leuprolidebicalutamide	
leuprolidebicalutamide	
CDX-1307	
CS3006	
PLB1001	
Lirilumab	
Birinapant	
Tripegfilgrastim	
PF-06936308	
APR-246	
APR-246	
APR-246	
APR-246	
CarboplatinPegylatedLiposomalDoxorubicinHydrochloride	
5-Fluorouracil5-FU	
GS-5829	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
MK-1454	
MAGE-A3ASCI	
MSC2490484A	
MSC2490484A	
MGD009	
Ad-P53	
XL184	
XL184	
XL184	
XL184	
XL184	
XL184	
BBI608	
D-0316	
GRT-C901	
GRT-R902	
LY3300054	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
Merestinib	
LY3321367	
Prexasertib	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
ABI-008	
GX-I7	
ETC-1922159	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
omega-3ethyl	
ALT-803	
ALT-803	
ETBX-021	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6301	
haNK®	
LXH254	
LXH254	
LXH254	
LXH254	
PDR001	
PDR001	
PDR001	
PDR001	
Anti-OX40antibody	
INC280	
INC280	
INC280	
INC280	
INC280	
PF-00299804	
Debio	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
BAY1905254	
adenovirus-p53SCH-58500	
NPI-0052	
LOR-253	
LOR-253	
KN046	
MSC2490484A	
MSC2490484A	
gemcitabinehydrochloride	
paricalcitol	Vitamin D3 Analog|Other anti-parathyroid agents|Enzyme Interactions|VITAMIN D,OTHER
paricalcitol	Vitamin D3 Analog|Other anti-parathyroid agents|Enzyme Interactions|VITAMIN D,OTHER
KITE-439	
VT-464	
VT-464	
VT-464	
ECO-4601	
ECO-4601	
Ad-MAGEA3	
MG1-MAGEA3	
Enzastaurin	
Viagenpumatucel-L	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
IMO-2125	
IMO-2125	
INC280	
INC280	
INC280	
INC280	
INC280	
ABI-009	
INCB007839	
LY3295668Erbumine	
INC280	
INC280	
INC280	
INC280	
INC280	
VX-984	
liposomaldoxorubicin	
GSK21110183	
MK-2118	
MK-2118	
Parsaclisib	
Parsaclisib	
Itacitinib	
INC280	
INC280	
INC280	
INC280	
INC280	
PF-04449913	
PF-04449913	
PF-04449913	
ARA-CLDAC	
LDAC	
MogamulizumabNivolumab	
TAK-659	
TAK-659	
MEK162inhibitor	
Paclitaxelmitoticinhibitorintravenous	
LY3214996	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
Encorafenib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|BRAF Serine/Threonine Kinase Inhibitors
KPT-9274	
KPT-9274	
KPT-9274	
KPT-9274Niacin	
CYH33	
ALRN-6924	
AG881	
ThymalfasinThymosin	
tyrosinekinaseinhibitor	
E7820	
E7820	
E7820	
HM781-36BPoziotinib	
Gefitinibradiotherapy	
docetaxel+lapatinib	
docetaxeltrastuzumab	
docetaxeltrastuzumablapatinib	
HER2Pembrolizumab	
IsatuximabSAR650984	
HPN536	
Teysunoepirubicinoxaliplatin	
BGB-290	
BGB-290	
BGB-290	
AT-101	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
MEK162	
MEK162	
MEK162	
MEK162	
Selicrelumab	
Selicrelumab	
Vanucizumab	
Vanucizumab	
GPX-150	
dovitinibTKI258	
VAX014	
AZD4547	
AZD4547	
AZD4547	
phenoxodiol	
PSMA/PRAME	
SunitinibmalateSU011248	
PLX4032	
PLX4032	
PLX4032	
PLX4032	
custirsensodium	
Nerofehormon-peptideTCApFsuppressive	
APG-1387	
APG-1387	
APG-1387	
Enadenotucirev	
M6620	
PR104	
PR104	
PR104	
CapecitabineXeloda	
INCB052793	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
INCB050465	
INCB039110	
INCB039110	
INCB039110	
Dovitinib	
CC-486	
gilteritinib	ANTINEOPLASTIC,OTHER
14C-labeledgilteritinib	
ABN401-Escalation	
ABN401-	
enzastaurin	
Selumetinib	
BDB001	
NOV1501ABL001	
AT-101	
STA-5312	
STA-5312	
PF-06821497	
PF-06821497	
PF-06821497	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
HER-2/neupeptidevaccine	
ABBV-075	
BBI503	
CKD-516	
CKD-516	
AZD4205	
AZD4205	
AZD4205	
BGB-283lifirafenib	
PD-0325901	
PD-0325901	
PD-0325901	
PD-0325901	
SBP-101	
PDC*lung01	
KeytrudaInjectable	
AlimtaInjectable	
Alisertib	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
Alisertib	
Obatoclaxmesylate	
mg/m2NKTR	
mg/m2NKTR	
mg/m2NKTR	
BMS-986207	
FostamatinibPaclitaxel	
tumor-specificTCR-T	
DS-8273a	
AZD9150	
AZD9150	
AZD9150	
AZD5069	
AZD5069	
AZD5069	
AZD5069	
AZD5069	
tremelimumabtreme	
DS-3032	
DS-3032	
DS-3032	
GRN163Ltrastuzumab	
AT13387	
AT13387	
AT13387	
abiraterone	Other hormone antagonists and related agents|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 17A1 Inhibitors|ANTINEOPLASTIC HORMONES|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 17A1 Inhibitor
Allogeneic	
AR-12	
AR-12	
AR-12	
AR-12	
mRNA-2416	
M7583	
LiposomalDoxorubicin	
Albumin-boundpaclitaxel	
Debio	
BBI503	
GL-ONC1	
ASTX727	
Pyrotinib	
SHR6390	
BBI608	
ZactimaZD6474	
Vinorelbinecisplatin	
Gemcitabinecisplatin	
ganitumab	
ABT-888mFOLFOX-6	
TBI-1301	
TAPA-pulsedvaccine	
BMS-833923	
BMS-833923	
CetuximabGefitinib	
TRK-950	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Hsp90Inhibitor	
LDE225	
LDE225	
DebioAT-406	
GDC-0032	
GDC-0032	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
IDC-G305	
MotexafinGadolinium	
H3B-6545	
ABT-510	
ABT-510	
Relatlimab	
Gefitinibcapecitabine	
AnetumabravtansineBAY94-9343	
CRLX101	
CRLX101	
MVT-2163	
MVT-5873	
ATP128	
LJM716	
VTX-2337	
VTX-2337	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
UB-921	
rHSA/GCSF	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
DivalproexSodium	
2-hydroxyflutamide2-HOFLiproca	
FPA008	
G1T38	
G1T38	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
BMS-833923	
BMS-833923	
BombesinBAY86-7548	
RadiumdichlorideXofigoBAY88-8223	
CTT1057	
CTT1057	
CTT1057	
CTT1057	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
nab-paclitaxelgemcitabine	
OxaliplatinFolinicFluorouracil	
OxaliplatinFolinicFluorouracilBevacizumab	
INCAGN02390	
MEDI0457	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
M200Volociximab	
LiposomalDoxorubicin	
LBH589PaclitaxelCarboplatinBevacizumab	
ABBV-927	
ABBV-368	
ABBV-181	
ABBV-181	
Satoreotidetetraxetan	
Satoreotidetrizoxetan	
Tepotinib	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Dovitinibdocetaxel	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Onvansertib	
Cedazuridine	
Cedazuridine	
Cedazuridine	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
5-Fluorouracil5-FU	
Lovaza	ANTILIPEMIC AGENTS
Lovaza	ANTILIPEMIC AGENTS
ALT-803	
ALT-803	
ETBX-011	
ETBX-021	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
BMS-690514FOLFIRI	
BMS-690514FOLFOX	
XmAb14045	
XmAb14045	
CP-751,871carboplatinpaclitaxel	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
MK-1496	
MK-1496	
MK-1496	
UCART19/ALLO-501	
CV9201	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
ThermoDox®LTLD	
MRx0518	
nesvacumabREGN910/SAR307746	
Epacadostat	
IPH2201	
IPH2201	
PI-88	
PI-88	
Perifosine	
Perifosine	
EZN-2208	
EZN-2208	
Vorolanib	
Vorolanib	
Vorolanib	
Brivanib	
Brivanib	
SHR3680	
SHR2554	
SHR3680	
galinpepimut-S	
MK-5890	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
VEGFinhibitorPTC299	
dHER2AS15ASCI	
CP-4055	
CP-4055	
DMXAAcarboplatinpaclitaxel	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
FOLFOX6Avastin	
SDX-7320	
Pembrolizumab/Exemestane/Leuprolide	
pemetrexeddisodium	
gene	
protein	
transcriptase-polymerase	
BAY2287411	
Brivanib	
Brivanib	
Icaritin	
Icaritin	
Icaritin	
BevacizumabHerceptin	
CKD602	
LiposomeMitoxantrone	
Bi-Weekly	
EZN-2208	
EZN-2208	
DSP-7888	
BBI608	
ZD6474vandetanib	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
ZD6474vandetanib	
ChAdOx1-MVAvaccine	
NivolumabOpdivo	
LEQ506	
LEQ506	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Interferonalfa-2a	
Interferonalfa-2a	
ziv-aflibercept	Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents
TEW-7197	
TEW-7197	
Chemotherapy	
LUM015	
MK2461	
MK2461	
MK2461	
MK2461	
MK2461	
MK2461	
NPI-0052marizomibvorinostat	
KU-0059436AZD2281PARPinhibitor	
LY2228820	
LY2228820	
rHuPH20	
rHuPH20	
pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
ziv-aflibercept	Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents
111-Indium-CMD-193	
CMD-193	
CMD-193	
peptideGM-CSFvaccinetrastuzumab	
autologousgp96	
Adriamycin	Topoisomerase 2 Inhibitors|ANTINEOPLASTIC ANTIBIOTICS|Anthracycline Topoisomerase Inhibitor|Topoisomerase Inhibitors|Anthracyclines and related substances
Enadenotucirev	
UCPVax	
89Zr-DFO-MSTP2109A	
DFO-MSTP2109A	
Tumorfluorescence	
IMA201	
ONT-10Varlilumab	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
LCL161	
LCL161	
LCL161	
LCL161	
GCSFPEG-GCSF	
DCVac-L	
TP-0903	
TP-0903	
TP-0903	
LupartumabAmadotinBAY1129980	
TLK286cisplatin	
ABT-751	
ABT-751	
ABT-751	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
BAY1075553	
lapatinibvinorelbine	
TransgenicLymphocyteImmunizationVaccine	
Rivoceranib	
REGN4018	
cemiplimab	ANTINEOPLASTIC,OTHER
cemiplimab	ANTINEOPLASTIC,OTHER
interferon-gammanivolumab	
NOV140101IDX1197HCl	
HS-10241	
Valproic	
Pexidartinib	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Radium-223dichlorideXofigoBAY88-8223	
KX2-391	
KX2-391	
KX2-391	
EIF4E	
APL-1202	
GemcitabineSorafenib	
KU-0059436AZD2281PARPinhibitor	
PBF-509_80	
PBF-509_160	
PBF-509_320	
PBF-509_640	
ComboPBF-509PDR001	
ComboPBF-509PDR001	
ComboPBF-509PDR001	
RP2DPBF-509+PDR001naïve	
Selumetinib	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
PEG-BCT-100	
ToripalimabHumanizedanti-PD-1Antibody	
SN2310Injectable	
PF-03446962	
IMA202	
TRK-950	
ABBV-085	
MS201408-0005A	
MS201408-0005C	
MS201408-0005B	
MORAb-066	
AZD5363	
AZD5363	
AZD5363	
AzacitidineVidaza	
Nab-paclitaxelAbraxane	
CB-839	
CB-839	
CB-839	
Pac-CB	
CB-Erl	
CB-Cabo	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
ACY-1215	
INCAGN02385	
ABR-217620	
ABR-217620	
TG01	
Prexasertib	
MM-310	
IMGN853	
LiposomalDoxorubicin	
Bevacizumab+Carboplatin	
Glumetinib	
Glumetinib	
Glumetinib	
Blood-stagevivax	
Torisel	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
IPI-504	
IPI-504	
LDE225	
LDE225	
BKM120	
BKM120	
GEN-1	
Radspherin	
F-627	
CapecitabineXeloda	
EGFR	
DS-1062a	
AZD2014AZD8186	
MobilanM-VM3	
EribulinCyclophosphamide	
MogamulizumabKW-0761	
FOLFOX6	
MKC-1	
MKC-1	
MKC-1	
RO6874281	
RO6874281	
RO6874281	
RO6874281	
PNT2258	
LBH589RAD001	
G1T38	
G1T38	
ASTX295	
BevacizumabAvastin	
ACIT-1	
GL-ONC1chemotherapybevacizumab	
Binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Tumor-InfiltratingLymphocytesTILs	
Interleukin-2IL-2	
CAR-T/TCR-Timmunotherapy	
ADI-PEG	
autologoustherapy	
IMA203	
MEDI7247	
INO-1400	
INO-9012	
INO-1401	
AZD9150	
AZD9150	
AZD9150	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
5-Flourouracil	
DTA-H19	
CDX-1140	
CDX-301	
FT500	
BGT226	
BGT226	
LDE225	
LDE225	
Wafarin	
MRX-2843	
Epacadostat	
Chemotherapy	
Epacadostat	
PM01183bevacizumab	
ARRY-334543EGFR/ErbB2inhibitor	
Gemcitabineintravenous	
capecitabine/oxaliplatin/bevacizumab/RAD001	
FOLFOX5-fluorouracilLeucovorinOxaliplatin	
LXH254	
LXH254	
LXH254	
LXH254	
LTT462	
MK-8628	
MK-8628	
FATE-NK100	
Avapritinib	
LY2875358	
LY2875358	
BPI-7711	
LenvatinibMesylate	
NexavarSorafenibirinotecanCampto	
hMN14labetuzumab	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
INCB062079	
RegorafenibBAY73-4506	
MGA271	
TalabostatMesylatePembrolizumab	
ErlotinibRosuvastatin	
RC48-ADC	
Lapatinibcapecitabine	
CVX-060	
CVX-060	
CPI-006	
CPI-006CPI-444	
CPI-006pembrolizumab	
BCD-100	
NIS793	
PDR001	
PDR001	
PDR001	
PDR001	
Imx-110	
AK104	
PD-0332991T-DM1	
V941	
AfatinibRibavirincarboplatin/paclitaxel	
CC-486	
NS-9Poly	
NP-G2-044	
NP-G2-044	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
AUY922	
AUY922	
AUY922	
AUY922	
AUY922	
JNJ-64619178	
NEO-201	
TRC105	
NIR178	
TNO155	
Spartalizumab	
Spartalizumab	
Spartalizumab	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
OBI-3424	
OBI-3424	
OBI-3424	
triapine	
triapine	
CVX-045	
CVX-045	
SNS-032	
SNS-032	
CNTO	
TEW-7197	
TEW-7197	
ridaforolimus	
ridaforolimus	
Enoblituzumab	
intoplicine	
CAB-AXL-ADC	
Camptothecincyclodextrin-basedpolymer	
triapine	
triapine	
Liposome-encapsulatedSN38	
HMPL-453	
EIF4E	
ADXS-503	
Tenalisib	
LUT014	
JTX-2011	
CART-TnMUC1	
MifepristoneEribulin	
MK-8776	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
GSK2126458	
GSK2126458	
GSK2126458	
XilonixOnivyde	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
BAY1000394	
BAY1000394	
BAY1000394	
BAY1000394	
BAY1000394	
BAY1000394	
REGN4659	
Cemiplimab	ANTINEOPLASTIC,OTHER
Cemiplimab	ANTINEOPLASTIC,OTHER
AGI-134	
AGI-134Pembrolizumab	
DS6051b	
BAY86-9766	
BAY86-9766	
Pyrotinib	
Topotecandoxorubicin	
TaporfinSodium	
IsatuximabSAR650984	
CemiplimabREGN2810	
MLN2480	
leronlimab	
leronlimab	
leronlimab	
leronlimab	
SU011248Capecitabine	
PDR001	
PDR001	
PDR001	
PDR001	
MGN1601	
Selinexor	
CC-115	
CC-115	
CC-115	
SB939	
SB939	
SB939	
TherapyWBRTsequentialDepocyte	
radiotherapyWBRTDepocyte	
BAL101553	
BAL101553	
ASTX029	
ALT-803	
ALT-803	
ASN007	
ASN007	
AZD4877	
AZD4877	
AZD4877	
Pimasertib	
EverolimusPanitumumab	
AutologousADP-A2M4CD8	
glioblastomavaccineIMA950	
PROSTVAC-V	
PROSTVAC-F	
PROSTVAC-F	
Neoantigenvaccine	
EC0489	
EC0489	
EC20	
EC20	
NexavarSorafenibBAY43-9006	
BAL101553	
SGM-101	
Vintafolide	
Vintafolide	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
L19IL2	
MGD007MGA012	
Satoreotidetetraxetan	
LGX818	
LGX818	
LGX818	
MEK162	
MEK162	
MEK162	
MEK162	
TKI258	
TKI258	
TisotumabvedotinHuMax-TF-ADC	
TQ-B3203	
Sym015	
GSK2141795	
GSK2141795	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
EC0225Folichydrazide	
Folicacid-technetium	
CORT125134nab-paclitaxel	
PF-04518600	
PF-04518600	
PF-04518600PF-05082566	
COTI2	
COTI2	
COTI2	
Thiarabine	
Thiarabine	
Thiarabine	
Thiarabine	
Thiarabine	
Thiarabine	
MLN6907	
LOAd703	
Vitamin	
CDX-1127	
CDX-1127	
RGX-202-01	
INC280	
INC280	
INC280	
INC280	
INC280	
erlotinibhydrochloride	
Tegavivint	
Tegavivint	
Tegavivint	
ODM-209	
vantictumab	
MPC-6827	
MPC-6827	
TalimogeneLaherparepvec	
ACY-1215	
TalaporfinSodium	
lapatinibtemozolomide	
racotumomab	
racotumomab	
AT-101	
IDE196	
itacitinib	
INCB050465	
PT-112	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
IPI-504	
IPI-504	
Alisertib	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
V935	
V934-EP	
Trametinibpediatric	
LY3039478	
LY3039478	
LY3039478	
Taladegib	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
LY3023414	
LY3023414	
LY3023414	
NPI-2358docetaxel	
CORT125281	
EnzalutamideXtandi	
VB10.NEO	
RAD001DocetaxelBevacizumab	
RogaratinibBAY1163877	
IMC-001	
SRA737	
Epacadostat	
Lirilumab	
INCB053914	
I-DACcytarabine	
Epacadostat	
erlotinibhydrochloride	
LY2784544	
LY2784544	
LY2784544	
FruquintinibSintilimab	
OMO-1	
erlotinibsunitinib	
durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
GM-CSFGM-CSFJX-594	
NaptumomabestafenatoxABR-217620durvalumabIMFINZIMEDI4736	
grapiprantpembrolizumab	
TSD-001	
PLX3397	
PLX3397	
PLX3397	
RegorafenibStivargaBAY73-4506	
CetuximabERBITUX	
TemsirolimusPazopanib	
CXD101Nivolumab	
BMS-986253	
TAS-120	
TAS-120	
TAS-120	
ATOR-1015	
Nal-Irinotecan	
PX-478	
PX-478	
PX-478	
GZ17-6.02	
TisotumabVedotinHuMax-TF-ADC	
VCN-01	
Abraxane®	
erlotinibhydrochloride	
ADCT-301	
AB928	
AB928	
AB928	
AB928	
AB122	
AB122	
AB122	
AB122	
FP-1305	
GM-CSFGM-CSFJX-594	
RheniumP2045BAY86-5284	
INBRX-105PDL1x41BBantibody	
Enfortumabvedotin	
BMS-986277	
BMS-986242	
Tivantinib	
FOLFOX	
FOLFOX	
PT-112	
BMS-986253	
CetuximabCarboplatin/Gemcitabine	
YN968D1	
YN968D1	
YN968D1	
CAN04	
AV-299gefitinib	
AB154	
AB122	
AB122	
AB122	
AB122	
MK-0646	
MK-0646	
ALKS	
ALKSpembrolizumab	
Toca	
NOX66	
brentuximabvedotin	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
M7824	
BYL719	
BYL719	
BYL719	
BYL719	
MEK162	
MEK162	
MEK162	
MEK162	
SRA737gemcitabinecisplatin	
SRA737gemcitabine	
OSI-906	
OSI-906	
OSI-906	
Indoximod	
REGN1400	
IsatuximabSAR650984	
THOR-707	
Checkpointinhibitor	
ROBO1CAR-NK	
C-14Rucaparib	
TPST-1120	
TPST-1120nivolumab	
TPST-1120docetaxel	
TPST-1120cetuximab	
TPST-1120	
TPST-1120nivolumab	
TPST-1120docetaxel	
TPST-1120cetuximab	
ADC-1013	
ADC-1013	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Interleukin-21	
Interleukin-21	
Interleukin-21	
STRO-002	
ALIMTA	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
PT2977	
ARRY-380HER2inhibitor	
LOXO-292	
2-hydroxyoleic	
CAB-ROR2-ADC	
BAY2731954	
Vaccine	
GX-I7	
LAG525	
LAG525	
PDR001	
PDR001	
PDR001	
PDR001	
ARRY-382	
SG001	
MKC-1	
MKC-1	
MKC-1	
pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
BVD-523	
JNJ-63723283	
GR-MD-02	
MP0250	
GRT-C903	
GRT-R904	
anti-PD-	
RV001V	
ODM-207	
BMS-986288	
MG005	
RO5503781	
RO5503781	
RO5503781	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
MetforminHydrochloride	
JI-101	
ABTL0812paclitaxelcarboplatin	
RC48-ADC	
ADI-PEGFOLFOX6	
BevacizumabEverolimusLBH589	
ZSP1602	
131-I-TM-601chlorotoxin	
LarotrectinibVitravkiBAY2757556	
PEN-221	
Antroquinonol	
Antroquinonol	
Antroquinonol	
PZP115891PCI-24781	
HC1119	
DS-8895amg/kg	
DS-8895amg/kg	
DS-8895amg/kg	
BMS-986310	
Birinapant	
antibody	
zoledronic	
BMS-986249	
AG-120	
ASTX660	
OGX-427	
BMS-986205	
BMS-986205	
Imatinibmesylateimatinibmesylatepanitumumab	
Standard-of-carepanitumumab	
PanobinostatLBH589Sorafenib	
BMS-986258	
rHuPH20	
rHuPH20	
TKM-080301	
BMS-986148	
RovalpituzumabTesirine	
CP-751,871	
BMS-986218	
lapatinibGW572016	
ETBX-011	
ALT-803	
ALT-803	
Relatlimab	
Cabiralizumab	
IDO1Inhibitor	
INBRX-109antibody	
PV-10bengaldisodium	
MEDI9447	
NC318	
BMX-001	
BMX-001	
BMX-001	
carboplatinpaclitaxel	
BMS-986158	
BMS-986158	
BMS-986158	
CP-547,632	
DCVAC	
DCVAC	
IMSA101	
checkpointinhibitor	
Immuno-oncologytherapy	
Relatlimab	
BMS-986205	
BMS-986205	
IrinotecanZD1839VincristineCefiximeCefpodoxime	
RogaratinibBAY1163877	
Cibisatamab	
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
PAC-1	
PAC-1	
plerixafor	Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer
osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
BMS-986178	
WX-0593	
AVX701	
Ganitumab	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
CTAP101	
PX-866	
PX-866	
Andecaliximab	
BMS-986156	
AZD9291AZD6094	
AZD9291selumetinib	
AZD9291non-Asian	
AZD9291intermittentselumetinib	
AZD9291MEDI4736	
AZD9291AZD6094	
AZD9291selumetinib	
AZD9291MEDI4736	
AZD6094monotherapy	
AZD9291AZD6094	
AZD9291AZD6094	
MGC018	
MGA012	
MGA012	
MGA012	
MGA012	
JAB-3312	
AGEN1884	
AGEN1884	
AGEN1884	
AGEN1884	
AGEN1884	
MitoxantroneHydrochlorideLiposome	
GS-4224	
Epacadostat	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
carbplatincyclophophamideatezolizumab	
CP-751,871	
LY2603618	
LY2603618	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Prexasertib	
APG-115+Pembrolizumab	
Durvalumab/chemotherapy	
Durvalumab/Tremelimumab/chemotherapy	
NKTR-214nivolumab	
NKTR-214ipilimumab	
Rosuvastatin10	
Midazolamsyrup	
SGN-CD47M	
TSR-011	
HLX07+Gemcitabine+Cisplatin	
HLX07+Paclitaxel+Carboplatin	
HLX07+mFOLFOX6	
OSI-906	
OSI-906	
OSI-906	
OSI-906	
OSI-906	
OSI-906	
BGB-A333	
BGB-A333BGB-A317	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
P16_37-63	
Pamiparib	
Pamiparib	
roniciclib	
Lucitanib	
GSK1120212B	
TAS-119	
PDR001	
PDR001	
PDR001	
PDR001	
BLZ945	
BLZ945	
BLZ945	
PDR001	
PDR001	
PDR001	
PDR001	
RefametinibBAY86-9766	
Vivomixx	
BAY1125976	
BAY1125976	
BAY1125976	
LGH447	
LGH447	
LGH447	
LGH447	
CCX872-B	
ORIC-101	
BAY86-9596	
BAY86-9596	
BAY86-9596	
BAY86-9596	
Fludeoxyglucose-IBA	
CX-072	
SL-279252	
TTI-621Monotherapy	
TTI-621PD-1/PD-L1Inhibitor	
calcitrioldocetaxel	
GEN1046	
DurvalumabTremelimumabFOLFOX	
BAL101553	
GC4419	
TrametinibGSK1120212	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Kanglaite	
Kanglaite	
BBI503	
vinflunineketaconazole	
BKM120	
BKM120	
2B3-101	
2B3-101mg/m2	
2B3-101mg/m2	
Brivanib	
Brivanib	
vinflunineixabepilone	
PRT543	
BVD-523	
TQ-B3234	
CS7017	
CS7017	
CS7017	
PaclitaxelGemcitabineSunitinib	
GX-I7	
AG-221	
AG-221	
PV-10bengaldisodium	
Zoledronic	
AL2846	
LAM-003	
Hu5F9-G4	
RegorafenibStivargaBAY73-4506	
Anti-PD-L1AntibodyMPDL3280A	
BMS-986148	
CS-7017	
CS-7017	
CS-7017	
Anti-SEMA4DAntibodyVX15/2503	
Defactinib	
BMS-986012	
INCB024360	
USL311	
USL311	
USL311	
USL311	
sonidegib	Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Hedgehog Pathway Inhibitor|Smoothened Receptor Antagonists
CS-7017	
CS-7017	
CS-7017	
BMS-986012anti-fucosyl-GM1	
TKM-080301	
ADXS31-164	
HS-10296	
vaccine	
PD-1	
BMS-777607	
BMS-777607	
BMS-777607	
Trilaciclib	
FF-10502-01	
Imprime	
FilgrastimG-CSF	
DoxorubicinHydrochloride	
MVA-FCU1flucytosine	
X-82	
X-82	
APL-101CBT-101	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
patritumab	
CTX110	
AZD4573	
APS001F	
FluzoparibApatinib	
CGX1321	
ARRY-520inhibitorintravenous	
Filgrastimgranulocyte-colonyG-CSFsubcutaneous	
Evofosfamide	
BexaroteneTargretin®	
erlotinibhydrochloride	
HM781-36B	
HM781-36B	
Somatuline	Somatostatin Analog|Somatostatin and analogues|ANTERIOR PITUITARY|Somatostatin Receptor Agonists
CBL0137	
CBL0137	
CBL0137	
PX-866	
PX-866	
ARRY-380	
ARRY-380	
ARRY-380	
ARRY-380	
ARRY-380	
ARRY-380	
ARRY-380	
ARRY-380	
Colo-Ad1	
Apatinib	
Apatinib	
Apatinib	
BGB-A425	
tislelizumab	
tislelizumab	
CB-839	
CB-839	
CB-839	
ATL001	
Afuresertib	
Entospletinib	
Gentuximab	
MitoxantroneNovantrone	
BortezomibPS-341	
ModraDoc006/r	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
IntratumoralIpilimumab	
KPT-8602	
Relatlimab	
HA121-28	
W0101	
W0101	
W0101	
Brivanib	
Brivanib	
APX005M	
APX005M	
APX005M	
Cabiralizumab	
KTN3379	
PQR309	
PQR309	
TinostamustineEDO-S101	
CYT-0851	
E7449	
E7449	
E7449	
E7449	
E7449	
E7449	
E7449	
E7449	
E7449carboplatinpaclitaxel	
microinjection	
PDR001	
PDR001	
PDR001	
PDR001	
progenitor	
DoxorubicinHydrochlorideLiposome	
CripecDocetaxel	
HumanizedAnti-PD-1Antibody	
SunitinibBortezomib	
hypoxia-activatedprodrugTH-302	
sorafenibtosylate	
anti-endosialin/TEM1antibodyMORAb-004	
AZD8055	
AZD8055	
AZD8055	
AZD8055	
BEZ235paclitaxel	
BKM120paclitaxel	
BEZ235paclitaxeltrastuzumab	
BKM120paclitaxeltrastuzumab	
XmAb13676	
XmAb13676	
Alisertib	
ErythropoiesisProteinNESPdarbepoetinalfa	
MEDI5083monotherapy	
MEID5083DurvalumabTremelimumab	
Medi5083DurvalumabDocetaxel	
MCS110	
PDR001	
PDR001	
PDR001	
PDR001	
EDP1503	
Sodiumbicarbonateg/kg/day	
Gemcitabinemg/m²	
BMS-986205	
BMS-986205	
PLX3397	
PLX3397	
PLX3397	
EDO-S101	
EDO-S101	
EDO-S101	
EDO-S101	
Dexrazoxane	Unknown Cellular or Molecular Interaction|Chelating Activity|PROTECTIVE AGENTS|Cytoprotective Agent|Detoxifying agents for antineoplastic treatment
Dacomitinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER
Dacomitinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER
PD-0325901	
PD-0325901	
PD-0325901	
PD-0325901	
Indoximod	
Indoximod	
BMS-833923XL139	
varlilumabnivolumab	
AZD6244	
AZD6244	
AZD6738carboplatin	
AZD6738	
AZD6738	
AZD6738	
AZD6738	
AZD6738olaparib	
AdministationAZD6738MEDI4736	
GW786034	
GW786034	
PI3KinhibitorBYL719	
linifanib	
AZD4547anastrozoleletrozole	
EribulinMesylate	
PVX-410	
ABBV-181	
ABBV-181	
ABBV-368	
ABBV-927	
satoreotidetrizoxetan	
M2ES	
BBI608Napabucasin	
PM01183olaparib	
T-1101Tosylate	
BiologicalsAntigen-SpecificImmunotherapeuticASCI	
MotexafinGadolinium	
AdV-tk	
BiologicalsAntigen-SpecificImmunotherapeuticASCIGSK2130579A	
allogeneicEpstein-Barrvirus-specificcytotoxic	
Urelumab	
GSK525762	
GSK525762	
GSK525762	
REGN2810	
REGN2810	
REGN2810	
DC-CIK	
TG02	
TG02	
TG02	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
PasireotidePasireotideEverolimus	
EverolimusPasireotideEverolimus	
PDR001	
PDR001	
PDR001	
PDR001	
ACZ885	
ACZ885	
CJM112	
TMT212	
CNTOAnti-interleukin-6antibody	
PazopanibGW786034	
Osimertininb	
PF-01367338	
CK-101	
CK-101	
CK-101	
IMU-131	
CisplatinFluorouracil5-FUCapecitabineOxaliplatincapecitabine	
dovitinib	
gemcitabinehydrochloride	
AZD5991	
AZD5991	
AZD5991	
AZD5991	
temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
vinorelbineditartrate	
CX-2029	
Binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
LY2787106	
GemcitabineHydrochloride	
LGX818	
LGX818	
LGX818	
TLK286	
XL888	
XL888	
BGJ398	
BGJ398	
BGJ398	
BGJ398	
amifostinetrihydrate	
irinotecanhydrochloride	
LOXO-292	
ABY-025	
PF-06801591	
BMS-690514	
BMS-690514	
BMS-690514	
REGN2810	
REGN2810	
REGN2810	
5-fluorouracil5-FU	
XL184	
XL184	
XL184	
XL184	
XL184	
XL184	
vaccine	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
AZD2014	
AZD2014	
AZD2014	
AZD2014	
AZD5363	
AZD5363	
AZD5363	
PLX3397	
PLX3397	
PLX3397	
MRx0518	
PembrolizumabMG/1IntravenousKEYTRUDA	
BAY2402234	
BKM120paclitaxelcarboplatin	
BKM120paclitaxelcarboplatin	
BKM120paclitaxelcarboplatin	
BKM120PaclitaxelCarboplatin	
DoxorubicinHydrochloride	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
IPH2101	
IPH2101	
IPH2101	
IPH2101	
siG12DLODER	
VS-6063	
CX-2009	
MetatinibTromethamine	
OxaliplatinIrinotecan	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
enzastaurin	
GP2013	
AZD1775	
pralsetinibBLU-667	
ZIO-101Darinaparsin	
EnapotamabvedotinHuMax-AXL-ADC	
GC4419	
Alisertib	
V930	
APX005M	
APX005M	
APX005M	
Binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Encorafenib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|BRAF Serine/Threonine Kinase Inhibitors
L-377202	
L-377202	
L-377202	
L-377202	
AG013	
ErlotinibDasatinib	
anlotinib	
anlotinib	
anlotinib	
Iso-Fludelone	
NivolumabOpdivo	
IpilimumabYervoy	
CMP-001	
Tazemetostat	
Tazemetostat	
NEO-PV-01	
4H11-28z/fIL-12/EGFRt+Genetically-modified	
GDC-0084	
GDC-0084	
GDC-0084	
FluMist	
ZD1839Iressa	
F-AraG	
nal-IRI	
NY-ESO-1c259	
RO5126766	
RO5126766	
FOLFOX	
FOLFOX	
MEHD7945A	
MEHD7945A	
MEHD7945A	
MEHD7945A	
CC-90011	
ilixadencel	
bivatuzumabmertansine	
radio-labeledOSI-906	
OSI-906	
OSI-906	
OSI-906	
CB-839	
CB-839	
CB-839	
CB-839dexamethasone	
CB-839pomalidomidedexamethasone	
^14C-alisertib	
alisertib	
VRx-3996	
VRx-3996	
GVAXpancreatic	
Urelumab	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
AZD9496	
CB-103	
CB-103	
CB-103	
ridaforolimus	
ridaforolimus	
Pemigatinib	
Pemigatinib	
GemcitabineCisplatin	
INCMGA00012	
RRx-001	
RRx-001	
RRx-001	
antibodyRAV12	
IrinotecanHydrochloride	
ImmunotherapeuticGSK2302025A	
Hu5F9-G4	
SagopiloneBAY86-5302	
KarenitecinBNP1350	
AndrogenTherapy	
BMX-001	
BMX-001	
BMX-001	
RO5083945	
RO5083945	
PaclitaxelTaxol	
CC-122	
CC-223	
CC-223	
CC-223	
CC-223	
CC-223	
CC-223	
LDE225	
LDE225	
pVAXrcPSAv53lrhesus	
BMS-986226	
Vaccine	
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
lymphocytealloreactiveT-cellsATIR	
rHSA/GCSF	
Talimogenelaherparepvec	
irinotecanhydrochloride	
alisertib	
IMMU-132	
IMMU-132	
VX15/2503	
VX15/2503	
VX15/2503	
zoledronic	
REGN2810monotherapy	
REGN2810	
REGN2810	
REGN2810	
GEN1029HexaBody®-DR5/DR5	
ICON-1	
Anti-PD-1AntibodyREGN2810	
porfimersodium	
gemcitabinehydrochloride	
STRO-001	
VEGFR/PDGFRkinaseinhibitorX-82	
DSP-7888	
CisplatinCapecitabineTrastuzumabMM-111	
LapatinibTrastuzumabMM-111	
PaclitaxelTrastuzumabMM-111	
LapatinibtrastuzumabpaclitaxelMM-111	
DocetaxeltrastuzumabMM-111	
89Zr-MMOT0530A	
MultiStem®	
TemsirolimusPaclitaxelCarboplatin	
TAS0728	
inhibitorMEK162	
leucovorincalcium	
Gemcitabinemg/m2	
1-28	
Bevacizumabmg/kg	
MEK162	
MEK162	
MEK162	
MEK162	
ImatinibMesylateGleevec®STI571	
TAS-102	
TAS-102	
TAS-102	
obuenseIMM-101	
Heat-killedM.obuenseIMM-101	
M.obuenseIMM-101	
vaccPoly-ICLCpeptide-pulseddendritic	
nanosomaldocetaxellipid	
Mycobacterium	
APX005M	
APX005M	
APX005M	
Radium-223BAY88-8223	
ADI-PEG	
TazemetostatTazemetostat	
FLX475	
AlloStim	
Pasireotidesub-cutaneous	
JCAR017	
JCAR017	
JCAR017	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
CC-122	
pemetrexedcisplatinCBP501	
pemetrexedcisplatin	
bevacizumabABT-510	
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
entolimod	
I124-NM404	
I124-NM404	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
TC-210	
anti-PD1	
MM-141	
CC-122	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
PI3KinhibitorBKM120	
Vosaroxin	
Vosaroxin	
perifosine	
perifosine	
OxaliplatinCapecitabineBevacizumabImatinib	
Resiniferatoxin	
Resiniferatoxin	
IntrathecalResiniferatoxin	
PRGN-3005UltraCAR-T	
MM-121	
Monalizumab	
Anti-PD	
PRI-724	
PRI-724	
TAS-102	
TAS-102	
TAS-102	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Zolbetuximab	
Zolbetuximab	
haplo/cord	
PLX2853	
LY3295668	
5-Azacitidine	
PEGPEM	
fruquintinib	
fruquintinib	
fruquintinib	
F-18BAY85-8050	
MTC-DOX	
Emibetuzumab	
CAR-Timmunotherapy	
DasatinibPaclitaxel	
KU-0059436AZD2281PARPinhibitor	
PaclitaxelCarboplatin	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Pimasertib	
PEN-866	
PEN-866	
PEN-866	
MDG1011	
KY1044	
KY1044	
Gallium68-labeledGRPRBAY86-7548	
MDV3100	
MDV3100	
MDV3100	
MDV3100	
TQ-B3233	
Wee-1kinaseinhibitorAZD1775	
Moxifloxacin	Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES
NY-ESO-1peptidevaccine	
liposomalhydrochloride	
Freund	
transcriptase-polymerase	
methylation	
A166	
Guadecitabine	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
VGX-3100	
VGX-3100	
VGX-3100	
FloxuridineOxaliplatinCPT-11	
TRX518	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
erlotinibhydrochloride	
ADH-1	
ADH-1	
ADH-1	
ADH-1	
MEDI7247	
Imatinibmesylate	
Glivecfilm-coated	
FOLFIRINOXIPI-926	
nab-paclitaxelgemcitabinecapecitabine	
BGB324	
BGB324	
CP-751,871	
177Lu-3BP-227	
Rovalpituzumabtesirine	
ALVAC-NY-ESO-1vaccine	
Luckyvec	
A-007	
A-007	
A-007	
TSR-042	
Carboplatin-Paclitaxel	
TSR-022	
CarboplatinPemetrexed	
Carboplatin-Nab-Paclitaxel	
ProTmune	
BMS-833923	
BMS-833923	
Selumetinib	
GB226	
Fruquintinib	
Fruquintinib	
Fruquintinib	
GSK1795091	
Guadecitabine	
BiologicalsAntigen-SpecificImmunotherapeuticASCI	
OPB-51602	
MLN8237Alisertib	
Monofer	
ParvovirusH-1PV	
GSK3326595	
GSK3326595	
GSK3326595	
5-azacitidine	
VAL201	
SAR245409	
SAR245409	
SAR245409	
GlutaminaseInhibitorCB-839	
IrinotecanHydrochloride	
DurvalumabTremelimumabcarboplatinetoposide	
Durvalumabcarboplatinetoposide	
Seviteronel	
APG115mono-therapy	
APG115Carboplatin	
Trioxide	
F16IL2	
INO-3112VGX-3100INO-9012CELLECTRA-5P	
alisertib	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
TAS-102	
EribulinMesylate	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
GVAX	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
LiposomalDoxorubicin	
AZD2014	
AZD2014	
AZD2014	
AZD2014	
AZD6244	
AZD6244	
pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
RO5126766	
RO5126766	
TG4001	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
BL-8040	
BL-8040	
Selicrelumab	
Selicrelumab	
Emactuzumab	
RO6874281	
RO6874281	
RO6874281	
RO6874281	
temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
CT053PTSA	
DNX-2401	
DNX-2401	
5-Fluorouracil5-FU	
hyaluronidasePEGPH20	
BL-8040	
BL-8040	
Gliolan	
AZD5363	
AZD5363	
AZD5363	
doxorubicin-GnRHAEZS-108	
Ridaforolimus	
Ridaforolimus	
CAL-101	
CAL-101	
TelaglenestatCB-839	
PalbociclibIbrance	
NBTXR3IMRT	
NBTXR3BrachytherapyIMRT	
MirvetuximabSoravtansine	
RucaparibCamsylate	
9-valent	
131I-TM-601	
GSK2141795	
GSK2141795	
OBP-301	
DN1406131	
BBI608	
MM-398	
SGX20117,21-dipropionate	
MV-NIS	
APR-246	
APR-246	
APR-246	
APR-246	
ATR-101	
FT-2102	
GemcitabineCisplatin	
Idasanutlin	
IntrathecalChemotherapy	
Poly-ICLCaPD-1NivolumabPembrolizumabaPD-L1AtezolizumabDurvalumab	
ImMucinhGM-CSF	
WT-1peptidevaccine	
Freund	
polymerase	
AZD6244	
AZD6244	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
ARGX-110	
SGN-CD70A	
SD-101	
SD-101	
SD-101	
RegorafenibStivargaBAY73-4506	
GemcitabineHydrochloride	
NKTR-262	
bempegaldesleukin	
bempegaldesleukin	
bempegaldesleukin	
ONCOS-102	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Eribulinmesilate	
Irinotecanhydrochloride	
BGB-290	
BGB-290	
BGB-290	
SNX-5422	
SNX-5422	
SNX-5422	
AZD6738	
AZD6738	
AZD6738	
AZD6738	
DKN-01	
AMXT1501	
CAR-T	
CAR-TPD-1	
PD-1	
PD-1	
GP-2250	
azacitadine	
rituximabIDEC-C2B8	
Lipo-MERIT	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
BR101801	
BR101801	
Sintilimab	
Sintilimab	
Sintilimab	
LiposomalPaclitaxelCisplatin	
Citarinostat	
PVX-410	
TSR-033	
TSR-033	
TSR-033	
TSR-033	
Anti-PD-1	
ALRN-6924	
hMN14labetuzumab	
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
ACP-319	
HM61713	
HM61713	
HM61713	
AEE788	
AEE788	
YY-20394	
VLS-101	
MB-002	
M6620	
BAY86-9596	
BAY86-9596	
BAY86-9596	
BAY86-9596	
ABT-869	
ABT-869	
AB-110	
SPARC1028	
ICP-022	
MIV-818	
RDEA119	
RDEA119	
CAR-T	
E7070irinotecan	
IrinotecanE7070	
APG-2575	
PDR001	
PDR001	
PDR001	
PDR001	
LCL161	
LCL161	
LCL161	
LCL161	
QBM076	
HDM201	
HDM201	
HDM201	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
TG-1701	
Umbralisib	
Ublituximab	
Ublituximab	
hMAbBIWA	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
CRS-100	
Hu5F9-G4	
OTX015/MK-8628	
F-18FMISO	
F-18	
SHC014748M	
BMS-986179	
rHuPH20	
rHuPH20	
IMG-7289	
IMG-7289	
IMG-7289	
retinoic	
PEP503	
SonazoidPerflubutane	
ganetespib	
AVN-944	
AVN-944	
AVN-944	
CeritinibLDK378	
TAK-901	
TAK-901	
TAK-901	
TregGraft	
AG881	
EverolimusRAD001	
Alisertib	
PDR001	
PDR001	
PDR001	
PDR001	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
Canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
Canakinumab	Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
RP6530	
CP-751,871	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
FT-1101	
XL888	
XL888	
OrcaGraft	
AST-008	
BIBW2	
BIBW2	
TivozanibAV-951	
Surface-ControlledCurcumin	
Surface-ControlledCurcumin	
Comparator	
Comparator	
escalation	
REGN1979	
AZD6244	
AZD6244	
ABR-217620	
ABR-217620	
UblituximabTGR-1202	
UblituximabTGR-1202ibrutinib	
UblituximabTGR-1202bendamustine	
AtalurenPembrolizumab	
SGN-35	
SGN-35	
HSC835	
CP-751,871	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Apatinib	
Apatinib	
Apatinib	
MEDI-522	
IPI-549	
IPI-549	
IPI-549	
anti-CEACAR-T	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
PDR001Imatinib	
oprozomib	
JNJ-64407564	
sunitinibmalateSutent	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
JNJ-64007957	
JNJ-64007957	
ADH-1	
ADH-1	
ADH-1	
ADH-1	
GemcitabineHydrochloride	
BMS-936564Anti-CXCR4	
MGCD265	
MGCD265	
MGCD265	
MGCD265	
MGCD265	
NanoliposomalIrinotecan	
TrifluridineTipiracilHydrochloride	
BPX-501	
AP1903	
AP1903	
AP1903	
TAK-788	
Sirolimusrapamycin	
ST571BYL719	
NT-I7	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
BKM120	
BKM120	
SPARC1023	
SPARC1023	
TQB2450	
BGB324	
BGB324	
Idasanutlin	
Myocet	
BMS-986205	
BMS-986205	
TAC-101	
TAC-101	
Derazantinib	
AtezolizumabHoffmann-LaRoche	
CB-839	
CB-839	
CB-839	
Ipatasertib	
Ipatasertib	
GemcitabineHydrochloride	
PaclitaxelAlbumin-StabilizedNanoparticle	
EphB4-HSAProtein	
Lonsurf	Unknown Cellular or Molecular Interaction|ANTINEOPLASTIC,OTHER|Thymidylate Synthetase Inhibitors|Nucleoside Metabolic Inhibitor|Antivirals|Nucleoside Analog Antiviral|Thymidine Phosphorylase Inhibitor|Nucleic Acid Synthesis Inhibitors|Thymidine Phosphorylase Inhibitors
GSK2110183	
GSK2110183	
GSK2110183	
GSK2110183	
ApatinibMesylate	
ApatinibMesylate	
AutologousCAR-T	
IMAB362	
Zoledronic	
Afuresertib	
AfuresertibHPMC	
Afuresertib	
Afuresertib	
AfuresertibHPMC	
Afuresertib	
HPV-16vaccine	
LY3214996	
AllogeneicAutologousTumor	
Binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Encorafenib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|BRAF Serine/Threonine Kinase Inhibitors
VEGFR/PDGFRKinaseInhibitorX-82	
DurvalumabTremelimumabmetronomicVinorelbine	
GSK2256098	
GSK2256098	
GSK2256098	
GSK2256098	
MEDI6469	
MEDI6469	
TLPLDCVaccine	
BPX-601	
Rimiducid	
RAD001Sunitinib	
RegorafenibBAY73-4506rifampin	
INT230-6	
anti-PD-1	
anti-PD-1antibody	
AVID100	
EVRIBMS-690514	
Rivogenlecleucel	
Rimiducid	
CD33-CAR-T	
dinaciclib	
dinaciclib	
brentuximabvedotin	
Escalation	
MK-8628	
MK-8628	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
AxitinibAG-013736	
IMP4297	
Perifosine	
Perifosine	
Perifosine	
Perifosine	
Perifosine	
Perifosine	
BGB-3111	
BGB-A317	
AVI-4126RESTEN-NG®	
INCB039110	
INCB039110	
INCB039110	
NiCord®	
ZevalinRadioimmunotherapy	
NiraparibCabozantinib	
TQB3456	
D-0502	
Fluzoparib	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
bendamustinehydrochloride	
AGS-16M8F	
BPI-9016M	
RO5126766	
RO5126766	
VS-6063	
Pimodivir	
BMS-986205	
BMS-986205	
SCB-313	
bevacizumabeverolimuspanitumumab	
Moxifloxacin	Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES
GDC-0810	
GDC-0810	
Gynoflor	
EGFRt/19-28z/4-1BBL	
Casopitant/Docetaxel	
selumetinib	
selumetinib	
Selumetinib	
Moxifloxacin	Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES
selumetinib	
11C-JNJ-63779586	
selumetinib	
selumetinib	
hLL1	
Mycophenolatemofetil	
Sulforadex	
alpha-cyclodextrin	
alpha-cyclodextrin	
ganetespib	
PazopanibTH-302	
Eribulinmesylate	
Eribulinmesylate	
HSPPC-96	
Itacitinib	
Calcineurininhibitor	
ABT-869	
ABT-869	
GL-ONC1	
IrinotecanCamptosarGefitinibIressa	
A317	
VTX-2337	
VTX-2337	
V212	
APG-1252	
OsimertinibMesylate	
Moxifloxacin	Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
NKR-2	
LXH254	
LXH254	
LXH254	
LXH254	
INC280	
INC280	
INC280	
INC280	
INC280	
EpoetinAlfa	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
NBTXR3	
SAR442085	
indibulin	
indibulin	
Heptapeptide	
IMCnyeso	
VK-2019	
TLR9SD-101	
Oraxol	
ipatasertib	
Tazemetostat	
Tazemetostat	
TG4050	
PRI-724	
PRI-724	
ModraDoc006/r	
ACY-1215pomalidomidedexamethasone	
GSK2857916	
AZD5363	
AZD5363	
AZD5363	
fluphenazinehydrochloride	
SNS-062	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
DoxorubicinHydrochloride	
icotinib	
icotinib	
icotinib	
CopanlisibBAY80-6946	
SPARC147609	
Reference147609	
hMN14labetuzumab	
AZD5069	
AZD5069	
AZD5069	
AZD5069	
AZD5069	
AZD6738	
AZD6738	
AZD6738	
AZD6738	
PHY906	
PHY906	
Erdafitinib	ANTINEOPLASTIC,OTHER
Erdafitinib	ANTINEOPLASTIC,OTHER
Cetrelimab	
Cetrelimab	
ONC201	
ONC201	
ONC201	
AutologousCD123CAR-CD28-CD3zeta-EGFRt-expressingLymphocytes	
CD123CAR-CD28-CD3zeta-EGFRt-expressing	
GW786034	
GW786034	
GW786034	
GW786034	
GW786034	
GW786034	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
PEG20	
Sulforadex	
cyclodextrin	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
POL6326	
CUE-101	
albuminsEphB4-HSA	
AutologouschimericantigenCD22	
Selinexor	
olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
TG60025-flucytosine5-FCAncotil®	
IRX-2	
IRX-2	
Lymfactin®	
Lymfactin®	
gluconate	
IMC-C103C	
gilteritinib	ANTINEOPLASTIC,OTHER
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Lovaza	ANTILIPEMIC AGENTS
Lovaza	ANTILIPEMIC AGENTS
ALT-803	
ALT-803	
ETBX-011	
ETBX-021	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
ClostridiumNovyi-NT	
AutologousCD19-targeting	
ET140202autologous	
GNS561	
VX15/2503avelumab	
Selumetinib	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
AutologousCAR-T	
NeoVax	
MB-CART19.1	
RamucirumabIMC-1121B	
levofolinate	
5-Fluorouracil5-FU	
Monalizumab	
CZ48	
CZ48	
CZ48	
MAK683	
ADXS11-001	
ADXS11-001	
trioxide	
MK-4280	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
ZN-e4	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
CAR-T	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Ublituximab	
Ublituximab	
CAR-T	
Radium-223dichlorideXofigo	
RO6958688	
RO6958688	
RO6958688	
RO6958688	
CPI-444	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Ipatasertib	
Idasanutlin	
TQ-B3525	
ASK120067	
Ublituximab	
Ublituximab	
CyclophosphamideZYC300ZYC300cyclophosphamidepre-dosing	
GTI-2040	
GTI-2040	
GTI-2040	
R-enantiomer1,2-dioleoyl-3-trimethylammonium-propanePeptidesHPV-16	
zolinza/vorinostat	
Tefinostat	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
Moxifloxacin	Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES
L19-IL2	
L19-IL2	
177Lu-DOTA-tyr3-OCTREOTATE	Various therapeutic radiopharmaceuticals|Somatostatin Receptor Agonists
liposomaldoxorubicindocetaxel	
chemotherapy	
Herceptin®	
CPI-0610	
SGN-30antibody	
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
methotrexatehydrocortisonecytarabineleucovorin	
TLK286docetaxel	
KHK2455	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Flt3L	
CT-P6	
LiposomalIrinotecan	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
PDC-1421	
CVA21	
MK-7252	
AAV2hAQP1	
monotherapy	
Guadecitabine	
NiCord®	
Osimertinib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors
FF-10501-01	
acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
vistusertib	
HDM201	
HDM201	
HDM201	
VaccineGM-CSF	
TJ107	
AbraxaneVandetanib	
Abraxanevandetanib	
FGF401	
PDR001	
PDR001	
PDR001	
PDR001	
BosutinibSKI-606	
MGD007	
F-627	
GIC-1001	
GIC-1001	
GIC-1001	
GIC-1001	
GIC-1002equimolarGIC-1001	
GIC-1002equimolarGIC-1001	
quadrivalentpapillomavirusvaccine	
polymerase	
NEO-PV-01	
APX005M	
APX005M	
APX005M	
CT053PTSA	
MLN0128	
MLN0128	
MLN0128	
MLN0128RP2D	
EPZ-5676	
EPZ-5676	
CPI-0610	
TAEST16001	
OctavalentAAHS	
OctavalentAAHS	
OctavalentAAHS	
OctavalentAAHS	
Comparator	
TRC105	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
ACTINIUM-225-LABELEDHUMANIZEDANTI-CD33ANTIBODYHuM195	
Adenoviral-mediatedInterferon-beta	
DC/tumorvaccine	
Guadecitabine	
APN201	
SunitinibMalate	
PF-05082566	
Sitravatinib	
Sitravatinib	
SitravatinibTislelizumab	
Sitravatinibtislelizumab	
TAK-385	
TAK-385	
BKM120	
BKM120	
AGS-003	
L19TNF	
AntibodyHu3F8	
Abemaciclib	Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
LY3023414	
LY3023414	
LY3023414	
Clofarabine/Busulfan	
AllogeneicMPBC	
NKTR-214	
CDX-301	
INO-5151	
Film-CoatedSandozInc.	
Film-CoatedCasodexAstrazeneca	
Film-CoatedCasodexAstrazeneca	
Film-CoatedSandozInc.	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
ONC201	
Quizartinib	
Intrathecalchemotherapyprophylaxis	
PHY906	
PHY906	
GC33RO5137382	
AdV-tkvalacyclovir	
TalimogenelaherparepvecTVEC	
Electrofusionvaccine	
intratumoralDNX-2401	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Calmette-Guérin	
APR-246	
APR-246	
APR-246	
APR-246	
GEN-009AdjuvantedVaccine	
DT01	
CX5461	
CX5461	
CX5461	
CX5461	
Cisplatincelecoxibvaccine	
CisplatinCelecoxibVaccine	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
9-valentVaccine	
H3B-6527	
H3B-6527	
H3B-6527	
Sorafenib50-mg	
Sorafenib50-mg	
Sorafenib50-mg	
Sorafenib200-mg	
TBI-1301	
TBI-1201	
PazopanibHydrochloride	
NanoDoce	
NanoDoceintravesical	
NanoDoceintravesical	
IL13-PE38QQR	
IL13-PE38QQR	
Temozolomidetherapy	
Toca	
Anti-AXLProteinAVB-S6-500	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
ASN-002	
F16IL2	
Toca	
Tivozanib	
AZD9150	
AZD9150	
AZD9150	
Lirilumab	
GSK461364	
GSK461364	
GSK461364	
GSK461364	
GSK461364	
EndoxanaLeukineIMA910	
EndoxanaLeukineIMA910Aldara	
anti-tumornecrosisantibody	
RRx-001WBRT	
brentuximabvedotin	
temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
Patritumab	
Dendritic	
INC280	
INC280	
INC280	
INC280	
INC280	
Milademetan	
Anti-LAG-3Antibody	
Anti-PD-1	
Anti-CD137	
FT516	
ADI-PEG	
FOLFOX4	
LY2157299	
LY2157299	
LY2157299	
MCY-M11	
vaccine	
ALECSATimmunotherapy	
granisetrontransdermal	
calciumleucovorin	
RBL001/RBL002	
Combig-DCallogeneicdendriticVaccine	
GC33	
Brivanib	
Brivanib	
STA-9090	
STA-9090	
BBI608	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
Complex-targetingCuraxinCBL0137	
IPI-145	
VAL-083Dianhydrogalactitol	
CAR2Anti-CEACAR-T	
perifosinetemsirolimus	
ZD6474vandetanib	
exatecanmesylate	
pazopanibhydrochloride	
MotexafinGadolinium	
tabelecleucel	
anti-CEACAR-T	
TTI-622Monotherapy	
TTI-622Rituximab	
TTI-622PD-1Inhibitor	
TTI-622Proteasome-inhibitorRegimen	
mg/m2RRituximab	
Cirmtuzumab	
Cirmtuzumab	
Cirmtuzumab	
Cirmtuzumabibrutinib	
Darbepoetinalfa	
Anti-PD-1DC-CIK	
Anti-PD-1	
ABI-1968	
G207oncolytic	
TNB-383B	
BYL719	
BYL719	
BYL719	
BYL719	
ACTR087	
SEA-BCMA	
RuxolitinibJakafi	
anti-CD19anti-CD20BispecificCAR-T	
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
bb2121	
Anti-CD19-CAR	
Anti-CD19-CAR	
EverolimusIntravesicalGemcitabine	
marizomib	
low-dosedexamethasone	
NANT-008	
FluorouracilInjectable	
AvastinInjectable	
LeucovorinCalcium	
EloxatinInjectable	
Atu027gemcitabine	
Atu027gemcitabine	
Atu027gemcitabine	
AV-MEL-1	
CarotuximabTRC105	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
ElotuzumabBMS-901608HuLuc63	
gemcitabineoxaliplatincapecitabine	
SOR007NanoparticlePaclitaxel	
FCN-159	
BT062	
Aurixim	
LY2127399	
LY2127399	
LY2127399	
REGN2810	
REGN2810	
REGN2810	
REGN1979	
SGN-40	
SPH1188-11	
SGN-40	
ADCT-402	
ADCT-402	
SGN-40anti-huCD40	
PTC299	
PTC299	
GSK2110183	
GSK2110183	
NeoAntigenVaccine	
Binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
GW786034pazopanib	
TAK-079	
ALT-803	
ALT-803	
Vorinostst/Bevacizumab/Temozolomide	
rhIL-2	
PNK-007	
IPI-504	
IPI-504	
anti-CEACAR-T	
MPH966	
YPEG-Filgrastim	
AZD6738	
AZD6738	
AZD6738	
AZD6738	
ABI-1968	
STA-9090ganetespib	
ABI-1968	
MP-470topotecan	
MP-470docetaxel	
MP-470erlotinib	
MP-470paclitaxel/carboplatin	
MP-470carboplatin/etoposide	
Guselkumab	Interleukin-23 Antagonist|Antibody-Receptor Interactions|Interleukin-23 Antagonists|IMMUNE SUPPRESSANTS|Interleukin inhibitors
LTX-315	
LTX-315	
LTX-315	
AxuminIntravenous	
Radspherin	
CVA21	
E6201	
E6201	
E6201	
PembrolizumabKeytruda	
BAY1841788ODM-201	
Gilteritinib	ANTINEOPLASTIC,OTHER
BortezomibVelcade	
LXS196	
LXS196HDM201	
pazopanibhydrochloride	
Perifosine	
Perifosine	
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
Temsirolimus	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor
KW-2478	
KW-2478	
KW-2478	
KW-2478	
BIWA	
AEB071	
CD4CAR	
Enzalutamide	ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor
Taselisib	
CyclophosphamideFludarabine	
Anti-NY-ESO-1	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
Temferon	
GM-CSFGM-CSFJX-594	
PD-0325901	
PD-0325901	
PD-0325901	
PD-0325901	
Binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
PF-00299804	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
isatuximabSAR650984	
CC-99712	
TAK-169	
BCMA	
Descartes-11	
CT053	
Measles	
MeaslesLumbar	
GSK2857916	
IsatuximabSAR650984	
HG146	
FOR46	
Bisthianostat	
SEA-BCMA	
EscalationMEDI2228antibody	
MEDI2228antibody	
CC-93269	
CAR2Anti-CD38CAR-T	
PBF-1129	
SGN-CD48A	
CC-92480	
pembrolizumabMK-3475	
Autologousanti-BCMAKITE-585	
ZIO-101Darinaparsin	
PT-112	
BFCR4350A	
bb21217	
PF-06863135	
DARA	
Regimen	
PDR001	
PDR001	
PDR001	
PDR001	
CJM112	
LCL161	
LCL161	
LCL161	
LCL161	
RO6870810	
CKD-581	
Gastro-Retentive	
Daratumumabmg/kg	
GMI-1271	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
DaratumumabSubcutaneous	
Isatuximab	
isatuximabSAR650984	
JNJ-54767414Daratumumab	
AtezolizumabMPDL3280Aanti-PD-L1antibody	
MK-0752DocetaxelPegfilgrastim	
ACY-241	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
IsatuximabSAR650984	
I-131-CLR1404	
Lirilumab	
Urelumab	
acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
LGH447	
LGH447	
LGH447	
LGH447	
BYL719	
BYL719	
BYL719	
BYL719	
Plitidepsin	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Oprozomib	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
SST0001Roneparstat	
HSV1716Intra-pleural	
isatuximabSAR650984	
Tabalumab	
CP-751,871	
JNJ-2641585VELCADEDexamethasone	
LGH447	
LGH447	
LGH447	
LGH447	
DFRF4539A	
JNS002	
Anti-CXCR4BMS-936564	
BMS-901608Elotuzumab	
BMS-901608Elotuzumab	
AVE1642	
AVE1642	
AVE1642	
YH25448	
MFGR1877S	
BI-505	
JNJ-26866138mg/m2	
JNJ-26866138mg/m2	
JNJ-26866138mg/m2	
SPARC147709	
Reference147709	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
ENMD-2076	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
ImetelstatSodiumGRN163L	
Comparator	
Comparator	
Comparator	
JX-594	
JX-594	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
ImetelstatSodiumGRN163L	
DasatinibLenalidomideDexamethasone	
DasatinibLenalidomideDexamethasone	
DasatinibLenalidomideDexamethasone	
DasatinibLenalidomideDexamethasone	
DasatinibLenalidomideDexamethasone	
Anti-KIR	
Vinflunine	
Perifosine	
Perifosine	
IntravenousMannose-BindingLectinrhMBL	
MBC-11	
HCD122	
OxycodoneOxyNorm®	
Investigational	
BKM120	
BKM120	
JCARH125	
ACY-1215Ricolinostatpomalidomidedexamethasone	
Selumetinib	
ST266	
AT7519M	
AT7519M	
AT7519M	
bendamustinelenalidomide	
BL-NHL	
BLR-CLL	
BLR-NHL	
quizartinib	
Polio/RhinovirusPVSRIPO	
Nab-PaclitaxelAbraxane	
rQNestin	
Ultratraceiobenguane	
RegorafenibStivargaBAY73-4506	
CarfilzomibDexamethasone	
isatuximabSAR650984	
cemiplimabREGN2810	
BT062intravenous	
PTX-9908	
X4P-001	
BT062	
L19TNF	
LJM716	
BYL719	
BYL719	
BYL719	
BYL719	
VELCADEbortezomib	
Revlimidlenalidomide	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
MEDI0562	
MEDI0562	
CCT301-38	
CCT301-59	
APO010	
PolatuzumabVedotin	
PI-88	
PI-88	
autologousdendritic	
BCX-1777	
BCX-1777	
BCX-1777	
IO102	
pembrolizumabKeytruda	
CarboplatinCarboplatinKabi	
PemetrexedPemetrexedAlvogen	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
GranulocyteColony-Stimulating	
CAR-BCMA	
IM21	
LCAR-B4822MCAR-TImmunotherapy	
CAR-TRe-treatment	
BCMAnanobodyCAR-T	
BCMAhuCART19	
BCMABCMAhuCART19	
Single-doseBCMABCMAhuCART19	
Selinexor	
EGFRt/BCMA-41BBz	
AutologousDNP-modifiedvaccineM-Vax	
AutologousDNP-ModifiedMelanomaVaccine	
AutologousDNP-ModifiedVaccine	
LDE225	
LDE225	
G-CSF	BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
HyperAcute-MelanomaVaccine	
chemotherapy	
Polatuzumabvedotin	
Polatuzumabvedotin	
MT-3724	
MT-3724	
Lipovaxin-MM	
Prophylaxis	
VX15/2503	
VX15/2503	
VX15/2503	
DEBIO1143	
DEBIO1143	
AutologousNY-ESO-1-specificCD8-positiveLymphocytes	
DendriticCell-targetingLentiviralID-LV305	
ImmunotherapeuticCMB305	
NiraparibNivolumab	
NiraparibIpilimumab	
MIK665	
MIK665	
MIK665	
SKI-G-801	
GEM333	
Itacitinib	
SLC-0111	
KHK7580	
CSL362	
CSL362	
AC220	
AC220	
AC220	
AC220	
AC220	
AC220	
DecitabineDacogen	
IMCgp100	
Plerixafor	Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer
MEDI-573	
GDC-0032	
GDC-0032	
VCN-01	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
MEDI4736tremelimumab	
MEDI4736+tremelimumab	
BortezomibPegylatedLiposomalDoxorubicinDexamethasone	
Selinexor	
peginesatide	Other antianemic preparations
4SC-201Resminostat	
efficacy	
efficacy	
LY3200882	
NanoliposomalIrinotecan	
polymerase	
Galunisertib	
BortezomibTipifarnib	
CPI-0610	
MonocyteKRN7000	
Tivozanib	
APN01	
CC-92480	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
CAR-BCMA	
BC-819/PEI	
Vaccine	
REGN5458	
GL-ONC1	
JNJ-68284528	
Melflufen	
Melflufen	
Descartes-08	
TAK-079	
PexastimogeneDevacirepvecPexa-Vec	
REGN2810	
REGN2810	
REGN2810	
P-BCMA-101CAR-T	
Rimiducid	
AUTO2	
TAK-573	
IsatuximabSAR650984	
CemiplimabREGN2810	
MP0250BOR+DEX	
LCAR-B38MCAR-T	
Radium-223dichlorideXofigoBAY88-8223	
ONC201	
ONC201	
ONC201	
IsatuximabSAR650984	
CC-220	
CC-220	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Selinexor	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Oprozomib	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Melflufen	
Melflufen	
Oprozomib	
Oprozomib	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Escalation	
ACY-1215	
MOR03087escalation	
MOR03087	
ACY-1215	
hLL1-DOXdoxorubicinmilatuzumab	
BKT140	
ARRY-520inhibitorintravenous	
Bortezomibproteasomeinhibitorintravenoussubcutaneous	
Filgrastimgranulocyte-colonyG-CSFsubcutaneous	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
P276-00	
MLN0128	
MLN0128	
MLN0128	
AUY922	
AUY922	
AUY922	
AUY922	
AUY922	
CKD-581	
BHQ880	
Zoledronic	
Perifosine	
Perifosine	
methylaminolevulinatehexaminolevulinate	
imexon	
XL184	
XL184	
XL184	
XL184	
XL184	
XL184	
MP0250DARPin®Osimertinib	
Atiprimod	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Selumetinib	
Nitroglycerin-citrate-ethanol	
MCLA-117bispecificantibody	
Pertuzumabtrastuzumab	
IDO1InhibitorBMS-986205	
famitinibcamrelizumab	
trabectedindurvalumab	
TilmanoceptTechnetium	
UltratraceIobenguaneMIBG	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
GSK2857916PomalidomideDexamethasone	
RPH-001	
Hu5F9-G4	
AutologousMulti-lineageAMPC	
CD123CAR-T	
OmnImmune®	
G-CSF	BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
Palifermin	Keratinocyte Growth Factor Receptor Agonists|Mucocutaneous Epithelial Cell Growth Factor|Detoxifying agents for antineoplastic treatment|HORMONES/SYNTHETICS/MODIFIERS,OTHER
Quizartinib	
AutologousAnti-BCMA-CAR-expressingCD4+/CD8+T-lymphocytesFCARH143	
BCMACAR-T	
Quizartinib	
Milademetan	
HMPL-523	
MAX-40279	
MAX-40279	
MAX-40279	
DecitabineDacogen	
DCLL9718S	
UCART123	
AMV564	
BAY1436032	
CT053PTSA	
Selinexor	
ADI-PEG	
ASP1235	
IndoximodFreebase	
Indoximod	
Indoximod	
JNJ-63709178	
IMGN779	
IxazomibMLN9708	
Selinexor	
Liposomaldoxorubicin	
AVID200	
MEN1112	
AtuveciclibBAY1143572	
pidilizumab	
SGN-CD33A	
gilteritinib	ANTINEOPLASTIC,OTHER
SGI-110	
SGI-110	
Gilteritinib	ANTINEOPLASTIC,OTHER
Gilteritinib	ANTINEOPLASTIC,OTHER
CabozantinibXL184	
RogaratinibBAY1163877	
PGX-ODSH-2013-AML-1	
IGN523	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
SGN-CD33A	
RO5503781	
RO5503781	
RO5503781	
RO5503781	
RO5503781	
RO5503781	
Volasertib	
RO5429083	
RO5045377	
Lenalidomideendoxanprednisone	
lenalidomideendoxanprednisone	
OCV-501	
Wild-typeReovirus	
OCV-501	
Thalidomide+Melphalan+Bortezomib+stem	
LenalidomideMelphalanautologous	
IPH2101	
IPH2101	
IPH2101	
IPH2101	
panobinostat/LBH589B	
AZD1152	
AZD1152	
AZD1152	
AZD1152	
Plerixafor	Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer
AZD1152	
AZD1152	
LDACcytosinearabinoside	
Trioxide	
Ascorbic	
ABT-888/Bortezomib	
Ganetespib	
TrisenoxTrioxide	
VelcadeBortezomib	
VitaminAscorbic	
AZD1152	
AZD1152	
AZD1152	
AZD1152	
Palifermin	Keratinocyte Growth Factor Receptor Agonists|Mucocutaneous Epithelial Cell Growth Factor|Detoxifying agents for antineoplastic treatment|HORMONES/SYNTHETICS/MODIFIERS,OTHER
Chemotherapy	
CSL360	
GM-CSF	
MLN518	
daunorubicinhydrochloride	
Ga-IMP-288	
SHR-1210	
SHR6390	
Vaccine	
BL-8040	
BL-8040	
CX-4945	
CX-4945	
CX-4945	
DurvalumabMEDI	
SEL24/MEN1703	
Voreloxincytarabine	
ADCT-602	
DoxorubicinHydrochloride	
Minnelide	
Minnelide	
Minnelide	
Filanesibpomalidomidedexamethasone	
Chemotherapy	
Merestinib	
LY2874455	
LY2874455	
LY2874455	
LY2874455	
carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
AutologousCD19-targeting	
Nirapaib	
MLN9708	
MLN9708	
MLN9708	
IL-12	
Selinexor	
DaunorubicinHydrochloride	
mitoxantronehydrochloride	
selinexor	
carfilzomibpanobinostat	
selinexor	
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
carfilzomiblenalidomidedexamethasone	
Defactinib	
LenalidomidePomalidomide	
BKM120	
BKM120	
plerixafor	Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer
BLZ-100	
therapydecitabinemidostaurin	
CCI-779	
CCI-779	
AK105	
IL13-PE38QQR	
IL13-PE38QQR	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
MIK665	
MIK665	
MIK665	
PX-866SCCHN	
CetuximabSCCHN	
PX-866	
PX-866	
ARRY-520inhibitorintravenous	
Filgrastimgranulocyte-colonyG-CSFsubcutaneous	
milatuzumab	
Vofatamab	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
TGR-1202	
Selumetinib	
KW-2478	
KW-2478	
KW-2478	
KW-2478	
GemtuzumabOzogamicin	
OPB-111077	
AC220	
AC220	
AC220	
CBT-1®	
KCP-330	
XL888	
XL888	
RO5045337	
RO5045337	
RO5045337	
helicobacterpylorivaccine	
HM43239	
Idasanutlin	
ECT-001UM171	
HDM201	
HDM201	
HDM201	
anthracycline	
liposomalcytarabine/daunorubicin	
gilteritinib	ANTINEOPLASTIC,OTHER
LiposomalAnnamycin	
LiposomalAnnamycin	
Onvansertib	
AZD2811	
AZD2811	
AZD2811	
FF-10101-01	
REOLYSIN®	
Chemotherapy	
CWP232291	
SPI-1620	
AG-120	
AG-221	
AG-221	
Idasanutlin	
G-CSF	BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
WT1/PRAME	
Crenolanibbesylate	
G-CSF	BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
TAK-659	
TAK-659	
GMI-1271	
Gilteritinib	ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
AL3818	
AL3818	
AL3818	
DCP-001	
PLX3397	
PLX3397	
PLX3397	
Freund	
SVN53-67/M57-KLHPeptideVaccine	
ARRY-520inhibitorintravenous	
Zosuquidar	
gemtuzumabozogamicin	
Zosuquidar	
IdarubincinAmufostineEthyol	
Idarubincin	
Chemotherapy	
Tivozanib	
BNC105P	
BNC105P	
BNC105P	
Anti-BCMACAR-T	
Cemiplimab	ANTINEOPLASTIC,OTHER
Cemiplimab	ANTINEOPLASTIC,OTHER
RituximabMethotrexate	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
MDX-1401	
BSCT	
Selinexor	
pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
BevacizumabGemcitabineDocetaxelValproic	
Immunotherapychemotherapy	
Immunotherapycyclophosphamidechemotherapy	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
INXN-1001	
INXN-3001	
BusulfanFludarabineCytoxan	
LY2510924	
LY2510924	
LY2510924	
Selinexor	
G-CSF	BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
oleclumab	
durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
nonpathogenicpolio-rhinovirusPVSRIPO	
Entospletinib	
Prophylaxis	
Ficlatuzumab	
Plerixafor	Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer
VorinostatEtoposide	
Tiragolumab	
Tiragolumab	
Plerixafor	Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer
Ga-IMP-288	
TAK-580	
allogeneic	
Alisertib	
SB-485232	
CD8+CD4+T-cells-expressingHA1-Specific	
KX2-391	
KX2-391	
KX2-391	
LDE225	
LDE225	
ALT02	
EU-licensedHerceptin	
US-licensedHerceptin	
AG-120	
AG-221	
AG-221	
SCM-010	
EnfortumabVedotin	
Hu5F9-G4	
Isatuximab	
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
INO-5401	
INO-9012	
5-Azacitidine	
Gemtuzumabozogamicin	
TRC105Pazopanib	
E7050	
E7050	
CV8102	
CV8102anti-PD-1therapy	
Rexin-G	
AvelumabMSB0010718C	
AxitinibAG-013736	
CX-4945	
CX-4945	
CX-4945	
doxorubicin-containing	
doxorubicin-containing	
doxorubicin-containing	
doxorubicin-containing	
AAVLP-HPV	
CCR2/CCR5	
GVAX	
VilaprisanBAY1002670	
Tyrosinekinaseinhibitor	
CHR-2797tosedostat	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
PRA-027	
Deoxycholic	
AutologousFecalMicrobiota	
IL13-PE38QQR	
IL13-PE38QQR	
APX005Mrecurrentmalignanttumor	
APX005MDIPG	
PDR001	
PDR001	
PDR001	
PDR001	
AdV-tk	
131-I-chTNT-1/B	
BPX-701	
Rimiducid	
Tecogalansodium	
Tecogalansodium	
Tecogalansodium	
Tecogalansodium	
temsirolimusliposomaldoxorubicin	
Lintuzumab-Ac225	
Immunotherapy	
EGFR-EDV-Dox	
VGX-3100	
VGX-3100	
VGX-3100	
talimogenelaherparepvec	
MEDI-565	
MEDI-565	
RamucirumabIMC-1121B	
MEK162	
MEK162	
MEK162	
MEK162	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
Light-activatedAU-011	
ZD6474vandetanib	
ZD6474vandetanib	
imexon	
Selinexor	
Temferon	
ING-1heMAb	
Oncoquest-CLLvaccine	
MB07133	
MB07133	
MB07133	
MB07133mg/m2/day	
MB07133mg/m2/day	
MB07133mg/m2/day	
MB07133mg/m2/day	
LY3114062	
LY3114062	
OROSHydromorphone	
EnzastaurinLY317615	
BLU-554	
PBF-509	
PBF-509	
ONO-7475	
SR-T100	
KX2-391	
KX2-391	
KX2-391	
Ingenolmebutate	
SR-T100	
Ingenolmebutate	
Zyclara®imiquimod	
DiclofenacSodium	
Solaraze®diclofenacsodium	
Ingenol	
Ingenol	
Ingenolmebutate	
PEP005Ingenolmebutat	
CNTO	
PEP005ingenolmebutate	
PEP005ingenolmebutate	
G207	
G207	
G207	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Pexidartinib	
EBViNT	
4SC-203	
4SC-203	
4SC-203	
GemtuzumabOzogamicin	
denileukindiftitoxE7777	
vaccine	
EPZ-5676	
EPZ-5676	
Betalutin	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
CV301	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Pelareorep	
CM-CS1T-cell	
CNTO	
PLX2853	
BMS-986205	
BMS-986205	
QuadrivalentPapillomavirusVaccine	
ingenol	
ingenol	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
CTAP201	
IngenolMebutate	
PRV111CisplatinTransmucosal	
ETBX-011	
ETBX-021	
ETBX-051	
ETBX-061	
GI-4000	
GI-4000	
GI-6207	
GI-6301	
haNK	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
N-803	
Cutaneous	
TBI-1301	
Ad26.HPV16	
Ad26.HPV18	
MVA.HPV16/18	
Avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
VBI-1901	
CD56-EnrichedLymphocyte	
BlinatumomabMT103	
VandetanibEtoposide	
AEG35156antisense	
BIIB022	
BIIB022	
BIIB022	
BIIB022	
AlvocidibDecitabine	
IVACMUTANOMERBL001/RBL002	
vaccine	
S65487	
TBI-1501	
CTT1057	
CTT1057	
CTT1057	
CTT1057	
Toca	
MEDI4736nab-paclitaxelgemcitabine	
MEDI4736AZD5069	
vaccine	
REOLYSIN®	
TransSodiumCrocetinate	
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
Cabozantinib	Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor
vaccine	
PTC596	
BPX-501	
AP1903	
AP1903	
AP1903	
AVL-292	
AVL-292	
EC-18	
EC-18	
EC-18	
AFXl-assistedingenolmebutate	
EC-18	
EC-18	
EC-18	
Oraxol	
anti-EGFRantibody	
RO5045337	
RO5045337	
RO5045337	
ALT-801	
ALT-801	
ALT-801	
ALT-801	
PTX-200	
CC-90009	
MDX-1342	
MDX-1342	
A-101	
A-101	
A-101	
A-101	
Ingenolmebutate	
Lintuzumab-Ac225	
STA-9090ganetespib	
Lintuzumab-Ac225	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
ONCOS-102	
Pemetrexed/cisplatincarboplatin	
GleevecRAD001Hydroxyurea	
SU011248Irinotecan	
erlotinibcetuximab	
GX-30THYROGEN®	
THYROGEN®GX-30	
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
Cabazitaxel	Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes
TP-0903	
TP-0903	
TP-0903	
TP-0903ibrutinibtherapy	
XIAPantisense	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
TalimogeneLaherparepvec	
Rimiducid	
rivogenlecleucel	
BPX-501	
rimiducid	
ASTX727	
iC9-CAR19	
AP1903	
AP1903	
AP1903	
APTO-253	
APTO-253	
APTO-253	
ALT-803	
ALT-803	
LGH447	
LGH447	
LGH447	
LGH447	
LGH447midostaurin	
mesylateimatinib	
ImatinibMesylate	
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
DabigatranEtexilate	
Tepotinib	
AR-42	
AR-42	
AR-42	
Ex-vivoprogenitor	
SAR103168	
PDR001	
PDR001	
PDR001	
PDR001	
MBG453	
ZactimaGleevecHydroxyurea	
G-CSF	BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
Plerixafor	Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer
AC220	
AC220	
AC220	
Imatinib/Acetaminophen	
TopotecanTemodar	
Omacetaxine	Protein Synthesis Inhibitors
Bortezomibmitoxantrone	
recMAGE-A3ProteinAS15	
CT53518	
CT53518	
TemodarO6-Benzylguanine	
ErlotinibDasatinib	
EphB4-HSAProtein	
VincristineLiposomal	
Custirsen	
Moxifloxacin	Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES
Givinostat	
Givinostat	
NS-018	
NS-018	
NS-018	
NS-018	
NS-018	
anti-CD123CAR-T	
P1101	
Betalutin	
AzacitidineLDE255	
AZD9150	
AZD9150	
AZD9150	
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
Acalabrutinib	Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER
AZD6738	
AZD6738	
AZD6738	
AZD6738	
Hu5F9-G4	
AZD5153	
AZD5153	
AZD5153	
AZD5153	
YS110	
DS-3201b	
HDM201	
HDM201	
HDM201	
JCAR017lisocabtagenemaraleucelsingle-dose	
JCAR017lisocabtagenemaraleucel2-dose	
duvelisib	ANTINEOPLASTIC,OTHER
Abemaciclibdexamethasoneixazomibpomalidomide	
Enasidenibdexamethasoneixazomibpomalidomide	
Cobimetinibdexamethasoneixazomibpomalidomide	
Erdafitinibdexamethasoneixazomibpomalidomide	
Venetoclaxdexamethasoneixazomibpomalidomide	
Daratumumabdexamethasoneixazomibpomalidomide	
WT1-sensitized	
bystandervaccine	
Varlilumab	
brentuximabvedotin	
inotuzumab+cyclophosphamide+vincristine+prednisone	
inotuzumabozogamicin+rituximab+gemcitabine+cisplatinum+dexamethasone	
aflibercept	Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents
ZarnestraR115777	
GleevecImatinibmesylate	
SGN-40	
binimetinib	Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER
encorafenib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|BRAF Serine/Threonine Kinase Inhibitors
Oblimersen-rituximab-fludarabine	
F-AraGanti-PD-1therapy	
AZD6738	
AZD6738	
AZD6738	
AZD6738	
Olaparib	Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor
Pemetrexed	Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues
SGN-40anti-huCD40	
AFM13	
SP-2577	
SP-2577	
SP-2577	
SP-2577	
INCB059872	
OblimersonsodiumG3139	
VilaprisanBAY1002670	
Ulipristal	CONTRACEPTIVES,SYSTEMIC|Progesterone Agonist/Antagonist|Emergency contraceptives|Progesterone receptor modulators|Selective Progesterone Receptor Modulators
OBP-301	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
Anlotinib	
Anlotinib	
Anlotinib	
TQB2450	
TK216	
EN3835	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
BMS-936558Anti-PD-1	
vaccineV3-Xcholangiocarcinoma	
hrBMP4	
IMP321	
IMP321	
IMP321	
IMP321	
IMP321	
PRA-027	
BMS-936558MDX1106-04	
PRA-027	
GCSF	
AP23573	
Ra-223Dichloride	
mitoxantronehydrochloride	
mg/kgGR-MD-02	
mg/kgGR-MD-02	
mg/kgGR-MD-02	
mg/kgGR-MD-02	
ACY-241	
PF-114	
PF-114	
PF-114	
bortezomibrifampicin	
bortezomibdexamethasone	
chemotherapy	
selumetinib	
K0706	
PVSRIPO	
Durvalumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
TCR-transduced	
avelumab	ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker
AZD1775	
APVAC1vaccinePoly-ICLCGM-CSF	
APVAC2vaccinePoly-ICLCGM-CSF	
Ficlatuzumab	
DMB-3111	
Pazopanib	Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors
Erlotinibsulindac	
imatinibmesylate	
APX005M	
APX005M	
APX005M	
ME-401	
CC-99282	
AB-205	
OT-82Escalation	
OT-82	
AutologousCD19-targeting	
AG-636	
CD19	
TG-1501	
CD19-TriCAR-T	
TRPH-222	
Mosunetuzumab	
Mosunetuzumab	
Polatuzumabvedotin	
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
RO7082859	
IM19	
CopanlisibAliqopaBAY80-6946	
RO7082859	
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
APX001anti-fungal	
B001	
C-CAR011	
TAK-659	
TAK-659	
HMPL-689	
RP4010	
DS-3201b	
ChimericAntigenImmunotherapyCAR-T	
RO7082859	
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
Tocilizumab	Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER
CD19CAR-T	
tazemetostat	
tazemetostat	
TAK-659	
TAK-659	
HBI-8000	
PolatuzumabVedotin	
ADCT-301	
BAY1862864	
lenzilumab	
IGN002	
IGN002	
DCDS0780A	
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
Carfilzomib	Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER
IntrathecalMethotrexate	
IntrathecalTherapyIntrathecalCytarabineHydrocortisoneMethotrexate	
Chimericanti-CD20antibody	
TGR-1202brentuximabvedotin	
microinjection	
AntibodyAnti-B1B-CellLymphomasTositumomabTositumomab	
BMS-906024	
BMS-906024	
BMS-906024	
ONO/GS-4059	
Clofarabine5-drugregimen	
DCC-2036	
DCC-2036	
SAR3419	
SAR3419	
SAR3419	
SAR3419	
L-0501	
InotuzumabOzogamicinCMC-544	
SEL120	
CAT-8015MoxetumomabPasudotox	
Everolmus	
MoxetumomabPasudotox	
MoxetumomabPasudotox	
SAR3419	
SAR3419	
SAR3419	
SAR3419	
beta-glucan	
beta-glucan	
beta-glucan	
Ad-MAGEA3	
MG1-MAGEA3	
bendamustinehydrochloride	
CAR-GPC3	
SBS-101	
Dengue-1	
Autologousmelanomalysatedendritic	
Dengue-1	
AME-133vLY2469298	
interleukin	
TG02	
